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9GENERAL INTRODUCTION
Figure 1. Location of the subarachnoid space.2
SAH accounts for 5% of all cases of stroke. Approximately 85% of the SAH cases is 
caused by a ruptured aneurysm in one of the cerebral vessels, this type of SAH is called 
aneurysmal subarachnoid haemorrhage (A-SAH). Ten percent of patients is diagnosed with 
a perimesencephalic subarachnoid haemorrhage (PM-SAH). This means that no aneurysm 
is found and the haemorrhage is restricted to the cisterns surrounding the brainstem and 
the suprasellar cistern.3 PM-SAH’s are often considered to have a benign clinical course.4 
The remaining 5% of patients have a non-aneurysmal, non-perimesencephalic SAH. They 
tend to have a clinical course similar to A-SAH.4
EPiDEmioLoGY
The incidence of SAH in the Netherlands in 2012 was 7.6 for men and 11.2 for women 
per 100,000 persons per year. The 1580 patients with SAH, that were admitted to a 
hospital in 2012, had a mean age of 57 for men and 61 for women.5,6 The mortality 
rate for patients with A-SAH is 35% in the first months after onset, and survivors have a 
decreased life expectancy and an increased risk for vascular diseases.4,7-9 For patients with 
SUBARACHNoiD HAEmoRRHAGE
Subarachnoid haemorrhage (SAH) is a spontaneous bleeding in the subarachnoid space. 
This space is located just above the brain under the arachnoid membrane (Figure 1).1
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PM-SAH the outlook is better. Mortality is less than 1% in this group, patients have a low risk 
for complications and their life expectancy is comparable to the general population.4,9,10
LoNG-tERm imPACt
One-third of the patients who survived A-SAH remain dependent.11 Months to years post-
onset, problems in cognitive and psychological functioning and subjective complaints, 
such as increased irritability may persist even when the degree of impairment in functional 
outcome is relatively mild.7 Approximately 25% of SAH patients with favourable neurological 
outcome (Glasgow Outcome Scale of 1) exhibit substantial emotional maladjustment.12,13 
Most problems are found in the cognitive domains of memory, executive functioning and 
language. Concerning functional outcome, problems are found in Activities of Daily Living 
(ADL), return to work and quality of life.7,8,14 Important problems associated with cognitive 
and functional outcomes after A-SAH are fatigue and mood disturbances.7,15 Although PM-
SAH is described as a benign form of SAH, there is growing evidence that these patients  may 
also experience cognitive problems, depression and difficulties in returning to work.4,16-18 
Gaining insight in the long-term impact of SAH is important. Patients are in the most 
productive stage of their life, in which work and family are important responsibilities.7 
At this stage of life the complications of SAH mentioned above, can have a major 
and long-lasting impact on the life of the patients and their families.19 Insight in 
the long-term functional impairments and psychosocial consequences of SAH 
has potential consequences for post-acute rehabilitation programs and long-term 
psycho-education and counselling.
oUtLiNE oF tHiS tHESiS
The main objective of this thesis is to evaluate the long-term consequences 4 years 
after subarachnoid haemorrhage, and to define which patients are in need of long-term 
professional support. Chapter 2 describes the differences in cognitive and emotional 
outcomes between patients with PM-SAH and A-SAH in the first year after SAH. It 
elaborates on the question if patients with PM-SAH indeed have a more favourable 
outcome one year post-onset than patients with A-SAH. Chapter 3 elaborates on the 
long-term consequences for patients with PM-SAH and investigates the relationships 
between fatigue, cognitive functioning, and mood. Furthermore, it is determined whether 
cognitive functioning differs between patients with and without fatigue. In Chapter 4 
a prospective study is described which assesses multiple outcomes for patients with 
A-SAH over a follow-up period of 4 years. The outcomes are evaluated based on all domains 
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of the International Classification of Functioning, Disability and Health (ICF) model and 
related to normative values. This chapter creates an overview of long-term consequences 
of A-SAH to help rehabilitation services in adapting their programs to long-term needs. 
Chapter 5 focuses on long-term community integration after SAH. It aims to identify [1] 
if cognitive functioning, depression and coping strategy are associated with community 
integration and [2] the level in which patients face unmet needs, questions that have not 
yet been addressed by health care providers. Chapter 6 is about the impact SAH may have 
on caregivers. This chapter investigates the relationship of coping style with depression, 
burden, and life dissatisfaction in caregivers. Chapter 7 is a general discussion based on the 
previous chapters. It describes the main findings of this thesis, discusses methodological 
considerations and proposes clinical implications and directions for future research. 
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patients with perimesencephalic and aneurysmal subarachnoid 
haemorrhage 
Wendy Boerboom, Majanka H. Heijenbrok-Kal, Ladbon Khajeh, 
Fop van Kooten, Gerard M. Ribbers
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ABStRACt
objectives: To compare cognitive and emotional outcomes between patients with 
aneurysmal- and perimesencephalic subarachnoid haemorrhage and norm scores.
Design: First measurement in prospective cohort study.
Patients: Sixty-seven patients with subarachnoid haemorrhage, divided into 
perimesencephalic (n=8) and aneurysmal (n=59) subarachnoid haemorrhage groups.
methods: Patients completed several questionnaires within the first year after haemorrhage. 
Depression was measured with the Center for Epidemiologic Studies Depression scale, 
fatigue with the Fatigue Severity Scale, and objective cognitive functioning with the Trail 
Making Test. Glasgow Coma Scale scores were collected at hospital admission.
Results: Perimesencephalic patients had lower depression (p=0.006) and lower fatigue 
scores (p=0.029) and were faster on the Trail Making Test A (p=0.002) than aneurysmal 
patients. No differences between the groups were found on Trail Making Test B (p=0.112) 
and presence of fatigue (p=0.105). Compared with norm scores, aneurysmal patients scored 
significantly worse on all outcomes, whereas perimesencephalic patients scored worse on 
Trail Making Test B (p<0.008), fatigue (p=0.073) and presence of fatigue (p=0.058).
Conclusions: Perimesencephalic patients may experience problems in complex cognitive 
functioning and fatigue. In this respect, they have similar sequelae as aneurysmal patients 
which may interfere with daily activities and social participation. These findings are of 
clinical relevance, as perimesencephalic patients often are discharged from hospital without 
long-term follow-up.
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iNtRoDUCtioN
Subarachnoid haemorrhage (SAH) is a subtype of stroke that occurs at a relatively young 
age. The mean age of onset of SAH is 55 years, compared with 70 years in men and 75 
years in women for stroke in general.1,2 The overall case fatality rate is 50% in population-
based studies. Only 5% of all strokes are SAH, with an incidence in the Netherlands of 5.8 
per 100,000 persons per year for men and 9.9 for women.3,4 In approximately 15% of all 
SAHs, no structural cause for the haemorrhage can be identified on radiographic imaging, 
termed angiogram-negative SAH, previously described as SAH of unknown origin or 
non-aneurysmal SAH.5-8 This group can be subdivided into perimesencephalic and non-
perimesencephalic angiogram-negative SAH.9-13 This study focuses on 2 subtypes of SAH 
based on the cause of the haemorrhage: aneurysmal subarachnoid haemorrhage (A-SAH) 
and perimesencephalic subarachnoid haemorrhage (PM-SAH).3 PM-SAH is defined as 
a haemorrhage restricted to the cisterns surrounding the brainstem and the suprasellar 
cistern combined with a negative angiogram.3,7,14 The cause of PM-SAH is unknown and no 
surgical treatment is required.3
A-SAH covers 85% of all SAH and is characterized by the rupture of an intracranial aneurysm 
and the subsequent accumulation of blood in the subarachnoid space.3,15 Neuroradiological 
intervention or neurosurgical clipping are the 2 options for treatment of the ruptured 
aneurysm.3,15 PM-SAH accounts for 10% of all SAH cases and the remaining 5% has various 
other causes.3,7 In 1985 van Gijn et al. first described PM-SAH as a benign form of SAH.16
Several studies have suggested that patients with A-SAH have a significantly less favourable 
prognosis than PM-SAH patients, based on the need for surgical or endovascular treatment, 
a risk of re-bleeding, shorter life expectancy and reduced quality of life.1,5,15,17-22 Of the 
patients who survive, approximately one-third remain dependent (Rankin grade 3-5).23 Even 
those who are independent may have cognitive impairments after recovery from A-SAH, 
in particular in the domains memory, executive functioning and language. Furthermore, 
half of the A-SAH patients experience mood disturbances and one-third experience 
fatigue.15,21,22,24 Therefore, the majority of patients with A-SAH are referred to inpatient or 
outpatient rehabilitation services or nursing homes for follow-up treatment.25,26
Patients with PM-SAH have a shorter length of stay in hospital, and are considered to 
experience good recovery not requiring follow-up treatment or meeting the criteria for 
rehabilitation services.27 Most studies showing these results are focused on survival and 
PERIMESENCEPHALIC VS ANEURySMAL SAH
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clinical outcomes.10,12,13,28,29 However, the premise of good functional outcome and cognitive 
functioning of PM-SAH is unclear. Only 2 studies were found confined to cognition and 
psychosocial outcome in the subgroup of PM-SAH patients.18,30 In these studies several 
problems are reported, such as cognitive deficits, depression, reduced activity levels, 
headaches, irritability and psychosocial problems, such as returning to a (current) job.18,30,31 
However, in a long-term follow-up study in angiogram-negative SAH patients, problems in 
selective attention during the first year of follow-up were found, which normalized within 
3 years.9 Two studies comparing the diverse group of SAH patients of unknown origin with 
selected A-SAH patients, reported impairments in diffuse cognitive functions, such as 
attention in the first group versus focal cognitive functions, such as short- and long-term 
memory, in the latter group.6,8 Outcome studies comparing isolated PM-SAH and A-SAH are 
not available, to our knowledge.
The aim of this study was to investigate the differences in cognitive and emotional outcomes 
of the subgroup PM-SAH and A-SAH patients in the first year after SAH. Based on the literature, 
we expect that patients with PM-SAH will have better outcomes than those with A-SAH, but 
we also expect to find cognitive problems and mood disturbances in patients with PM-SAH 
that might require medical attention or follow-up treatment in rehabilitation services.
mEtHoDS
Participants and procedures
All patients diagnosed with SAH, who were hospitalized between 2006 and 2009 at the 
neurology or neurosurgery department of the Erasmus University Medical Center Rotterdam, 
were screened for participation in this study. Inclusion criteria were: at least 18 years of 
age and survival of SAH at least until hospital discharge. Exclusion criteria were: serious 
comorbidity resulting in a short life expectancy less than 1 year and insufficient mastering 
of the Dutch language. Patients who agreed to participate were asked to sign an informed 
consent form. The study was approved by the Medical Ethics Committee of Erasmus MC.
Data collection
The presence of SAH was determined by computed tomography (CT) or lumbar puncture. 
The cause of SAH was determined using CT angiography or digital subtraction angiography. 
PM-SAH was defined by accumulation of blood around the mesencephalon on CT and a 
normal 4-vessel angiogram.3,14 
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During hospitalization baseline socio-demographic data and clinical characteristics, such as 
type, location and severity of SAH, and type of rehabilitation (none, outpatient, or inpatient 
rehabilitation) were collected by the staff of the neurology or neurosurgery department. 
Within the first year after SAH a research psychologist visited the patients at home to collect 
different measurements, which included validated questionnaires for depression and 
fatigue, and an objective test for cognitive functioning. Data were collected by 3 trained 
research psychologists.
Normative data from healthy subjects were obtained from the literature for each of the 
questionnaires and for the cognitive functioning test.32-34
Measurement instruments
The Barthel Index (BI) is used to evaluate the patient’s state of independence. The 
total score ranges from 0 to 20, where 0 is completely dependent and 20 is completely 
independent.35
Glasgow Coma Scale scores (GCS) were collected as a measure of the severity of the SAH. 
The GCS is a scale to measure 3 different aspects of impaired consciousness and coma: 
motor response, verbal response and eye opening. The total score ranges from 3 to 15, of 
which the higher scores represent a higher level of consciousness.36 In this study the first 
GCS score during hospital admission was used. These scores were assessed by physicians of 
the hospital department. 
The Center for Epidemiological Studies Depression scale (CES-D) was used to measure 
emotional outcome. CES-D is a 20-item scale used to measure depressive symptoms over 
the previous week in a general population. This scale is validated in stroke patients.37 Scores 
range from 0 to 60 and the higher the score, the more depressive symptoms are present. 
Scores of 16 or higher are an indication of presence of depression.32,37,38 
The Fatigue Severity Scale (FSS) was used to measure the severity of fatigue. The 
questionnaire has 9 statements on fatigue in daily life. The patient can score these statements 
on a 7-point Likert scale ranging from 1 to 7, where 1 is “strongly disagree” and 7 is “strongly 
agree”. Based on literature, patients with fatigue are distinguished from healthy controls if 
the mean score of the 9 items is 4 or higher.33 
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Total SAH (n=228)
Eligible (n=116)
Analyzed (n=67) 
• Died (n=63)
• Excluded (n=30)
• Missed (n=19)
• Declined (n=20)
• Lost (n=29)
The Trail Making Test (TMT), parts A and B, were used as a measure of cognitive functioning. 
The TMT is widely used and has been researched extensively. The TMT score is a 
neuropsychological measure that is sensitive to a wide range of neurocognitive deficits.39 
The TMT is a pen and paper task to measure cognitive flexibility. In part A, which measures 
motor speed and processing speed, patients are asked to connect 25 numbered dots in 
ascending order as quickly as possible. In part B, which measures processing speed and 
divided attention, the 25 dots contain numbers and letters and the patient must connect 
the dots alternating between a number and a letter. The measured time (with a maximum 
of 180 sec.), including extra time for correcting potential errors, is recorded to calculate a 
time score.40
Statistical analysis
Statistical analyses were performed using SPSS version 19 (SPSS Inc, Chicago, USA). 
Descriptive statistics were used to describe the general population characteristics. Means 
and standard deviations (SDs) were calculated for interval variables and numbers and 
percentages for categorical variables. Mann-Whitney U tests were used to analyse the 
differences between patients with PM-SAH and those with A-SAH for the variables: GCS, CES-D 
and FSS and independent-samples t-test for the TMT-A and TMT-B scores. Fisher’s exact tests 
were used to test the differences between the SAH types of the categorical variables: gender, 
education (≥high school), hypertension, smoking, presence of depression (CES-D>16) 
and presence of fatigue (FSS>4). Type of rehabilitation (inpatient/outpatient/none) was 
tested with the χ2 test. 
CHAPTER 2
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To test for potential selection bias, differences between the groups of missed patients 
and included patients (see Figure 1) were evaluated. For all analyses a significance level of 
p<0.05 was used.
Comparisons of the PM-SAH and A-SAH group with norm values of healthy subjects were 
performed with independent-samples t-tests and Fisher’s exact tests, using a statistical 
internet tool (GraphPad Software Inc, La Jolla, CA, USA).
RESULtS
Study population
From a total of 228 patients with SAH, who were hospitalized in the neurology or 
neurosurgery department of the Erasmus MC between April 2006 and August 2009, 67 
were eligible for inclusion in the study. The flow of patients is shown in Figure 1. Eight of 
the included patients had a PM-SAH (11.9%) and 59 patients had an A-SAH (88.1%). None 
of the patients in this sample was diagnosed with non-perimesencephalic angiogram-
negative SAH. The mean age of the study population was 53.1 years (SD 11.6) and 37.3% 
were male. The mean length of hospital stay was 15.3 days (SD 9.9). Patient characteristics 
are presented in Table I.
PERIMESENCEPHALIC VS ANEURySMAL SAH
Analyzed 
group 
(n=67)           
missed
group 
(n=29) p-value
Age, years, mean (SD) 53.1 (11.6) 56.4 (12.0) 0.207a
Length of hospital stay, days, mean (SD) 15.3 (9.9) 16.3 (9.0) 0.645a
GCS, mean (SD) 13.2 (3.4) 12.2 (4.0) 0.218b
Time after SAH, months, mean (SD) 5.6 (8.6) NA NA
Type of bleeding, perimesencephalic, n (%) 8 (11.9) 3 (10.3) 1.000c
Gender, men, n (%) 25 (37.3) 11 (37.9) 1.000c
Education, ≥high school, n (%) 32 (47.8) NA NA
Hypertension, n (%) 29 (43.9) NA NA
Smoking, n (%) 27 (40.9) NA NA
a t-test; b Mann-Whitney U test; c Fisher’s exact test.
SAH: subarachnoid haemorrhage; GCS: Glasgow Coma Scale score; SD: standard deviation; NA: not available.
table i. Patient characteristics.
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Pm-SAH
(n=8)
Pm-SAH
(n=8)
Pm-SAH
vs A-SAH
p-value
Age (years), mean (SD) 48.9 (10.4) 53.6 (11.7) 0.278a
Time after SAH, months, mean (SD) 3.2 (2.5) 6.0 (9.1) 0.390a
Length of hospital stay, days, mean (SD) 7.1 (6.6) 16.4 (9.8) 0.012a
GCS, mean (SD) 14.8 (0.5) 13.0 (3.5) 0.121b
BI, mean (SD) 19.9 (0.4) 18.6 (2.9) 0.051b
Gender, men, n (%) 6 (75.0) 19 (32.2) 0.045c
Type of Rehabilitation, n (%) 0.230d
    Inpatient 0 (0.0) 16 (27.1)
    Outpatient 1 (12.5) 7 (11.9)
    None 7 (87.5) 36 (61.0)
Education, ≥high school, n (%) 5 (62.5) 27 (45.8) 0.464c
Hypertensiond, n (%) 3 (37.5) 26 (44.8) 1.000c
Smokingd, n (%) 2 (25.0) 25 (43.1) 0.455c
a t-test; b Mann-Whitney U test; c Fisher’s exact test; d χ2test.
SAH: subarachnoid haemorrhage; GCS: Glasgow Coma Scale score; BI: Barthel Index score.
Compared with the A-SAH group, the PM-SAH group contained significantly more men and 
had a shorter length of stay (Table II). BI score, age and other patient characteristics did not 
differ significantly between the 2 groups. Rehabilitation type was also not significant. One 
PM-SAH patient received outpatient rehabilitation for cognitive complaints only. From the 
A-SAH patients 27.1% received inpatient rehabilitation including multidisciplinary functional 
and cognitive therapy. Table III presents the results of the questionnaires and cognitive 
testing. The PM-SAH patients had lower depression scores and fatigue scores compared 
with A-SAH patients. None of the PM-SAH patients had a significant depression (CES-D≥16) 
No significant differences were found between the groups of missed patients and included 
patients for any of the variables available: type of bleeding, gender, age, length of stay and 
Glasgow Coma Scale scores (Table I). Data were complete for 92.5% of the TMT-A, 89.6% of 
the TMT-B, 83.6% of the FSS and 77.6% of the CES-D. The main reason for the missing data was 
the length of the test battery: time restrictions or fatigue were reasons for not finishing the 
test battery. Sum scores could sometimes not be calculated because of missing item scores. 
Comparison between PM-SAH and A-SAH patients
CHAPTER 2
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versus 20 (44.4%) in the A-SAH group. However, the proportion of PM-SAH patients with 
fatigue (FSS score≥4) was not significantly different from the A-SAH patients. For the tasks 
of cognitive functioning significant differences were found at the TMT-A. Patients with 
PM-SAH were faster on this task than those with A-SAH. No significant differences were 
found between the 2 groups on the more complex TMT-B task.
Comparison PM-SAH versus norm values
Comparing the results with the scores of a normal healthy population we found that patients 
with A-SAH scored significantly worse on all outcome measures. PM-SAH patients scored 
significantly worse than the norm population on the more complex TMT-B task (Table III). In 
addition, the mean fatigue scores of the patients with PM-SAH and the proportion of these 
patients with a FSS score ≥4 were borderline significant compared with the healthy subjects. 
No significant differences were found for the depression scores and the TMT-A task.
table iii. Comparisons of outcomes between PM-SAH, A-SAH patients, and norm values.
Pm-SAH n A-SAH n
Norm
values n
Pm-SAH 
vs A-SAH
p-value
Pm-SAH 
vs norm
p-value
A-SAH 
vs norm
p-value
CES-D, mean (SD) 5.0 (4.9) 7 13.9 (8.7) 45 8.2 (7.2) 255 0.006b 0.244a 0.000a
CES-D ≥6, n (%) 0 (0.0) 7 20 (44.4) 45 32 (12.7) 255 0.035c 0.601c 0.000c
FSS, mean (SD) 3.1 (1.6) 8 4.5 (1.4) 48 2.3 (0.7) 20 0.029b 0.073a 0.000a
FSS ≥4, n (%) 3 (37.5) 8 34 (70.8) 48 1 (5.0) 20 0.105c 0.058c 0.000c
TMT-A, mean (SD) 33.0 (8.3) 7 47.9 (20.1) 56 31.8 (9.9) 41 0.002a 0.764a 0.000a
TMT-B, mean (SD) 87.0 (42.4) 7 118.8 (49.1) 56 63.8 (14) 41 0.112a 0.008a 0.000a
a t-test; b Mann-Whitney U test; c Fisher’s exact test.
CES-D: Center for Epidemiologic Studies Depression Scale score; FSS: Fatigue Severity Scale score; TMT-A 
and TMT-B: Trail Making Test A and B scores; SD: standard deviation.
DiSCUSSioN
Our results show disturbed cognitive and emotional outcomes in patients with PM-SAH, 
also found in other studies.18,30,31 The cognitive task, TMT-A, indicates that patients with PM-
SAH have no problems in processing and motor speed, in contrast with patients with A-
SAH, which is in agreement with our hypothesis. However, the results on the more complex 
TMT-B task indicate that both groups of SAH patients perform worse than a normative 
sample. This implies that divided attention is affected in both the PM-SAH and A-SAH 
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patients. This confirms the findings of Madureira et al. (2000), in which 72% of the patients 
with PM-SAH showed neuropsychological deficits and Hütter et al. (1994), who found 
similar cognitive deficits in non-A-SAH patients in comparison with A-SAH patients.6,18
Another notable finding in our study is that the proportion of patients with PM-SAH with 
fatigue did not differ significantly from that of patients with A-SAH, and it almost significantly 
differed from the normative scores. To our knowledge, fatigue was not investigated in other 
studies with validated questionnaires in patients with PM-SAH. This finding suggest that 
patients with PM-SAH, like those with A-SAH, do experience fatigue, which is described as 
a common complaint after SAH.24
Contrary to our expectations, none of the patients with PM-SAH in our study reached the 
CES-D cut-off score of 16, which indicates clinical depression. This finding differs from 
earlier literature in which, besides the cognitive deficits symptoms of depression in PM-SAH 
patients are also reported.9,18,30 A possible explanation is that, in our study, the majority of 
patients with PM-SAH was male. Gender is a known predictor for symptoms of depression, 
and could therefore have influenced the outcome of the CES-D.32 In the study of Madureira 
et al. (2000), for example, 66% of the patients with PM-SAH with depression were female. 
Of the patients with A-SAH in our study, 44.4% had clinical depression.1,15,18 The difference 
between A-SAH and PM-SAH might be explained by the different prospects of both groups. 
Patients with PM-SAH do not require surgical or radiological treatment and get an excellent 
clinical prognosis without the risk of a re-bleed and without follow-up treatment, whereas 
A-SAH patients are faced with complex treatment, high complication rates, a survival chance 
of only 50%, a high risk of recurrence and many of them face months of rehabilitation.1,15 
Although the results of this study of impaired complex cognitive functioning and fatigue in 
patients with PM-SAH confirm previous research findings, not much has changed in terms 
of follow-up treatment for patients with PM-SAH in the Netherlands. Patients with PM-SAH 
often are discharged from hospital without long-term follow-up because of their good 
prognosis. Based on our results, this policy should be questioned. 
This study has some limitations. The first is that there were only 8 PM-SAH and 59 A-SAH 
patients enrolled in the study. Even with this small number of PM-SAH patients we did find 
significant cognitive deficits compared with a normal population. In terms of percentage, 
this number fits the incidence of 10% of all SAH patients. In further research a larger sample 
is required to confirm that PM-SAH patients experience fatigue. Another limitation might 
CHAPTER 2
25
be that the measurement time, within the first year after the haemorrhage, was not the 
same for all patients, and no follow-up measurements were done. In recent research it was 
found that cognitive complaints may diminish within 3 years of follow-up.9 Finally, cognitive 
testing was limited to the TMT test, which is a good test to measure processing speed and 
mental flexibility. In future studies other domains of cognitive functioning, such as long-
term memory and sustained attention, should be measured in a larger sample over a longer 
follow-up.
In conclusion, contrary to the assumed favourable outcome, patients with PM-SAH may 
experience impaired complex cognitive functioning and fatigue. In this respect patients 
with PM-SAH have similar sequelae as those with A-SAH, which may interfere with daily 
activities and social participation. These findings are of clinical relevance, as patients with 
PM-SAH often are discharged from hospital without long-term follow-up. Based on our 
results this policy should be questioned. 
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ABStRACt
Purpose: To study relationships between fatigue and objective and subjective cognitive 
functioning, mood, and comorbidity in the long term after perimesencephalic subarachnoid 
haemorrhage (PM-SAH).
methods: Cross-sectional study. Objective cognitive functioning was measured with: Trail 
Making Test; Symbol Substitution; D2; Verbal and Semantic Fluency; Tower Test; Digit Span; 
15-Words Test; Rey Complex Figure. Subjective cognitive functioning: Cognitive Failure 
Questionnaire. Fatigue: Fatigue Severity Scale. Mood: Hospital Anxiety and Depression 
Scale.
Results: Forty-six patients, mean age 50.4 (SD 9.4), mean time after PM-SAH 4.7 (SD 1.6) 
years participated. Patients with fatigue (33%) had significantly lower scores than patients 
without fatigue on most objective cognitive functioning tests (p<0.05). Fatigue score was 
significantly associated with subjective and objective cognitive functioning, mood, and 
comorbidity. After adjustment for mood and comorbidity, fatigue remained associated 
with attention and executive functioning.
Conclusions: This study supports our previous findings that a third of patients with 
PM-SAH experience fatigue and problems of cognitive functioning, also in the long term. 
Future research should investigate whether these patients would benefit from long-term 
follow-up and/or cognitive rehabilitation programs.
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iNtRoDUCtioN
In about 10% of the cases of subarachnoid haemorrhage, patients are diagnosed with a 
perimesencepahlic subarachnoid haemorrhage (PM-SAH). This means that no aneurysm 
is found and the haemorrhage is restricted to the cisterns surrounding the brainstem 
and the suprasellar cistern, combined with a negative angiogram.1,2 Although this type 
of subarachnoid haemorrhage (SAH) is often described as a benign form of SAH with 
favourable outcomes, we found that patients with PM-SAH may experience problems in 
executive functioning and fatigue.3 
The long-term relationship between fatigue and cognitive functioning after PM-SAH has 
not extensively been studied. Most of the long-term outcome studies focus on clinical 
outcomes or quality of life.4-7 Despite good clinical outcome7, quality of life outcomes are 
contradictory. Two studies4,6 reported long-term complaints or reduced vitality and general 
health, whereas one study reported no long-term reduction in quality of life.5 Hütter et al. 
(1994), Madureira et al. (2000), and Krajewski et al. (2014) did focus on cognitive outcomes 
in patients with PM-SAH or other types of non-aneurysmal SAH (broader group).8-10 They 
determined minor cognitive deficits in their patients, but did not study fatigue in relation 
to cognitive functioning. Passier et al. (2011) described various factors such as physical 
and cognitive impairments, mood disturbances like anxiety and depression, and a passive 
coping style to be associated with fatigue after aneurysmal SAH.11 In an earlier study we 
found that 38% of the subgroup of patients with PM-SAH (n=8) suffered from fatigue 3.2 
(SD 2.5) months post-onset.3 In view of the expected favourable outcome in patients with 
PM-SAH, we considered this a surprising outcome that asked for replication in a larger 
population. The data registries of two university medical centres were used to obtain a larger 
group of patients with PM-SAH that could be tested extensively on cognitive functioning. 
We were interested whether the experienced cognitive problems that were found around 
3 months after PM-SAH also exist in the long term. The aim of this study was to investigate 
the relationships between fatigue, cognitive functioning, and mood in the long term after 
PM-SAH. The second aim was to determine whether cognitive functioning differs between 
patients with and without fatigue after PM-SAH. If fatigue is related to problems in cognitive 
functioning, than this should be taken into account in tailoring (cognitive) rehabilitation 
programs for these patients.12
LONG-TERM FATIGUE AFTER PM-SAH
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mEtHoDS
Participants and Procedures
All patients diagnosed with PM-SAH, hospitalized between 2006 and 2012 at the 
neurology and neurosurgery departments from the Erasmus University Medical 
Center Rotterdam or the University Medical Center Utrecht, were screened for participation 
in this study. PM-SAH was defined by accumulation of blood around the mesencephalon 
on CT and a normal 4-vessel angiogram. Inclusion criteria were: PM-SAH, and at least 18 
years of age. Exclusion criteria were: all other types of stroke or SAH, serious (neurological) 
comorbidity and insufficient mastering of the Dutch language. All patients who were willing 
to participate provided informed consent. The Medical Ethics Committee of the Erasmus 
MC and UMC Utrecht approved the study.
Data collection
The staff of the neurology and neurosurgery departments in both hospitals identified 
all patients diagnosed with PM-SAH from a data registry of all SAH patients hospitalized 
between 2006 and 2012. Patients received an information letter from their neurologist and 
were invited to participate in the study. After informed consent was obtained from eligible 
patients, a research psychologist visited the patients at home to collect various outcome 
measures. A structured interview was used (patient characteristics and pre- and post-injury 
employment status), and validated questionnaires for depression, fatigue, comorbidity 
and subjective cognitive functioning. Furthermore, objective tests were used for multiple 
domains of cognitive functioning, which included memory, executive functioning, attention, 
concentration, speed of information processing and visuoconstruction. 
Measurement instruments
Questionnaires
Fatigue was assessed using the Fatigue Severity Scale (FSS). The questionnaire contains 9 
statements on fatigue in daily life. The patients scored these statements on a 7-point Likert 
scale ranging from 1 to 7, with 1 indicating “strongly disagree” and 7 indicating “strongly 
agree”. Patients with fatigue are distinguished from healthy controls if the mean score over 
the 9 items is 4 or higher.13 
The Cognitive Failure Questionnaire (CFQ) measures self-perceived cognitive failures in 
daily life. It consists of 25 items for which participants indicate on a 5-point scale (range 0-4) 
how often they experience cognitive failures in daily life. A sum score is calculated (range 
CHAPTER 3
35
0-100) in which higher scores indicate an increased experience of cognitive problems.14 
‘Normal’ scores range from 21 to 43 (mean 31.8; SD 11.1), a cut-off score >43 is used to 
distinguish normal scores from abnormal scores.15
To measure the degree of depression and anxiety in patients, the Hospital Anxiety and 
Depression Scale (HADS) was used. This questionnaire exists of 7 questions related to 
anxiety and 7 related to depression. The answers are given on a 4-point scale (range 0-3) 
and a total sum score is calculated. A higher sum score indicates more emotional problems. 
The scores 0-7 are defined as no anxiety or depression, 8-10 as probable cases and 11-21 as 
definite cases.16,17
Comorbidity was measured with the Cumulative Illness Rating Scale (CIRS). This list consists 
of 14 disorders and diseases (including SAH), which are rated on a 5 point rating scale, 
ranging from 0 (disorder/disease not present) to 4 (life-threatening disorder/disease 
present).18 Patients were classified as having symptoms of comorbidity if they had a score 
above 5.19
Neuropsychological tests
The Trail Making Test (TMT), was used to measure cognitive functioning on the domains 
speed of information processing (part A) and divided attention, which was classified as 
a task of executive functioning (part B). The measured time to complete the task (with a 
maximum of 180 sec.), including extra time for correcting potential errors, was recorded 
to calculate a time score.20,21 Norm scores by age group and education were obtained from 
Tombaugh (2004).22 
The D2 test of attention and concentration was used to measure visual selective attention, 
processing speed and concentration. A total performance score and a concentration 
performance score was determined. The total performance score was calculated from the 
total of processed items minus total missed items and total wrong items; the concentration 
performance score is based on the total identified correct items minus total identified 
wrong items.23
The Digit Span is a subtest of the Wechsler Adult Intelligence Scale-III (WAIS-III), and was 
used to measure attentional span and working memory. The maximum scores for the 
forwards and backwards series are 16 and 14, respectively.24
LONG-TERM FATIGUE AFTER PM-SAH
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The Symbol Substitution task (SS) is a subtest of the WAIS-III, and was used to measure speed 
of information processing. The total number of correctly completed items is counted.24
The Fifteen Word Task (15WT, Dutch version) was used to measure learning, delayed recall 
and recognition. Raw scores were calculated for the immediate total (15WT-TRS) recall (range 
0 to 75), delayed (15WT-DRS) recall (range 0 to 15) and for the recognition task (15WT-rec) 
(range 0-30). A cut-off score ≤26 is used to distinguish normal scores from abnormal scores 
for the recognition task.25
To measure semantic memory (category fluency) and executive functioning (phonological 
fluency) the Word Fluency task (WF) was used. The total score consists of the total correct 
items named per task in respectively 2 and 1 minute.26
The Tower Test (TT) from the Delis-Kaplan Executive Functioning System (D-KEFS) measures 
executive functions like planning and problem-solving abilities. A total performance score 
is calculated taking time and total amount of moves into account.27
The Rey Complex Figure Task (RCFT) was used to measure visuoconstructional skills (copy) 
and incidental memory (recall). Patients receive points for correctly placed lines, the total 
score for both copies is used.25
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics version 21 (SPSS Inc, Chicago, 
USA). Descriptive statistics were used to describe the study population characteristics. Means 
and standard deviations were calculated for interval variables and numbers and percentages 
for categorical variables. Differences in patients, SAH characteristics and cognitive outcomes 
between fatigued and non-fatigued patients were tested with independent samples t-tests. 
Dichotomous or categorical variables were calculated with a χ2 or Fisher’s Exact test in case 
of small groups. Relationships between subjective and objective cognitive test outcomes, 
fatigue, depression scores, and comorbidity scores are expressed in Pearson correlations. 
Relationships between fatigue and cognitive functioning were adjusted for depression and 
comorbidity using partial correlations. T-scores were calculated based on clinical reference 
scores, adjusted for age and education level for each individual. T-scores in the range of 40 
to 60 are considered normal.23-27 The mean scores of TMT and CFQ were also compared with 
published norms using independent samples t-tests.15,22 A significance level of p<0.05 was 
used for all analyses. Bonferroni corrections were performed to correct for multiple testing 
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for the comparisons between patients with and without fatigue, resulting in a significance 
level of p<0.003. 
RESULtS
Study population 
From a total of 109 patients with PM-SAH, 46 agreed to participate in the study, 20 from 
Erasmus MC Rotterdam and 26 from University Medical Center Utrecht. The flow of patients 
is shown in Figure 1. The mean age of the total group was 50.4 (SD 9.4) years, and 63% 
were men. An overview of the patient- and clinical characteristics is displayed in Table I. In 
this study sample 33% suffered from fatigue (mean 3.4; SD 1.3). The differences between 
fatigued and non-fatigued patients are also presented in Table I. Although not significant, 
patients with fatigue were less likely to have a paid job after PM-SAH. Furthermore, patients 
with fatigue had significantly higher scores on the CIRS comorbidity scale and the HADS 
depression scale.
Figure 1. Flow of patient inclusion.
Total PM-SAH patients  
contacted (n=109)
Total included (n=46)
• No response (n=20)
• Not interested (n=24)
• Exclusion criteria (n=19)
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table i. Demographic and clinical characteristics for Fatigued (Fatigue Severity Scale (FSS) ≥4) 
vs Non-Fatigued (FSS<4) patients with PM-SAH.
total 
group
N=46
Fatigued 
n=15 
(32.6%)
Non- 
Fatigued 
n=31 
(67.4%)
Fatigued  
vs Non- 
Fatigued 
p-value
Age of onset (years), mean ± SD 50.4 ± 9.4 50.5 ± 9.3 50.3 ± 9.6 0.936
Gender (men), n (%) 29 (63.0) 10 (66.7) 19 (61.3) 0.723
Partner (yes), n (%) 39 (84.8) 15 (100) 30 (96.8) 1.000
Education (high), n (%) 19 (41.3) 4 (26.7) 15 (48.4) 0.161
Hypertension (yes), n (%) 12 (26.1) 7 (46.7) 5 (16.1) 0.038
CIRS total score (mean) ± SD 4.0 ± 3.0 6.5 ± 3.5 2.8 ± 1.7 0.001
Pre-morbid employment status, n (%) 0.733
    Employed 36 (78.3) 11 (73.3) 25 (80.6)
    Retired 4 (8.7) 2 (13.3) 2 (6.5)
    Unemployed 6 (13.0) 2 (13.3) 4 (12.9)
Current employment status, n (%) 0.075
    Employed 29 (63.0) 6 (40.0) 23 (74.2)
    Retired 7 (15.2) 4 (26.7) 3 (9.7)
    Unemployed 10 (21.7) 5 (33.3) 5 (16.1)
Hospital discharge destination, n (%) 0.674
    Home 45 (97.8) 15 (100) 30 (96.8)
    Inpatient rehabilitation 1 (2.2) 0 (0.0) 1 (3.2)
Time post-onset (years), mean ± SD 4.7 ± 1.6 4.9 ± 1.5 4.6 ± 1.7 0.597
HADS (depression score), mean ± SD 3.6 ± 3.6 6.4 ± 3.0 2.1 ± 3.0 <0.001
Probable depression HADS ≥8, n (%) 7 (15.2) 5 (33.3) 2 (6.5) 0.029
FSS (fatigue score), mean ± SD 3.4 ± 1.3 5.0 ± 0.6 2.7 ± 0.7 <0.001
CIRS: Cumulative Illness Rating Scale; HADS: Hospital Anxiety and Depression Scale, FSS: Fatigue Severity Scale
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table ii. Mean scores and differences in Cognitive Test outcomes; Fatigued (Fatigue Severity 
Scale (FSS) ≥4) vs Non-Fatigued (FSS<4) patients with PM-SAH.
total group 
N=46
mean ± SD
Fatigued 
n=15
mean ± SD
Non- 
Fatigued 
n=31
mean ± SD
Fatigued 
vs Non-
Fatigued 
p-value
Subjective cognitive functioning
CFQ, Total score 36.3 ± 14.6* 42.2 ± 15.4* 33.5 ± 13.5 0.056
CFQ Score >43, n (%) 12 (26.1) 7 (46.7) 4 (12.9) 0.024
Attention and concentration
D2, Concentration performance 166.4 ± 41.9 137.2 ± 39.9 179.6 ± 31.1 0.001#
Digit Span, Forward 8.6 ± 1.7 7.6 ± 1.2 9.0 ± 1.8 0.007
Speed of information processing
D2, Total performance 420.1 ± 96.3 353.2 ± 99.8 450.3 ± 79.2 0.001#
TMT-A (max. 180 sec.) 32.0 ± 10.9 39.1 ± 11.6* 28.6 ± 8.8 0.001#
Symbol Substitution, Total good 69.5 ± 17.3 56.5 ± 17.6 75.8 ± 13.3 <0.001#
Memory
15 WT, Total score 44.0 ± 9.8 38.5 ± 10.1 46.6 ± 8.6 0.007
15 WT, Total recall 9.2 ± 2.9 7.3 ± 3.0 10.1 ± 2.4 0.001#
15 WT, Total recognition 29.0 ± 1.3 28.3 ± 1.2 29.3 ± 1.2 0.006
Rey Complex Figure, Recall score 19.9 ± 5.7 17.5 ± 6.5 21.0 ± 5.0 0.051
WF, Semantic 34.7 ± 7.8 31.4 ± 7.9 36.4 ± 7.3 0.042
Digit Span, Backward 6.5 ± 2.2 5.6 ± 1.5 6.9 ± 2.4 0.061
Digit Span, Total score 15.1 ± 3.5 13.3 ± 2.5 15.9 ± 3.6 0.014
Executive functioning
Tower Test, Total performance 17.3 ± 4.6 15.4 ± 4.4 18.2 ± 4.5 0.067
WF, Phonological 23.2 ± 7.3 19.5 ± 5.0 25.1 ± 7.6 0.014
TMT-B (max. 180 sec.) 75.2 ± 30.9* 87.8 ± 40.3* 69.0 ± 23.5 0.052
Visuoconstruction
Rey Complex Figure, Copy score 33.1 ± 2.5 33.1 ± 2.7 33.1 ± 2.5 0.939
Missings: D2: n=1; Tower Test: n=1
CFQ: Cognitive Failure Questionnaire; TMT: Trail Making Test; 15 WT: 15 Words Task; WF: Word Fluency. 
* Mean scores worse than healthy individuals (p<0.05)
# Significant after Bonferroni correction (p<0.003)
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table iii. Proportions of patients with abnormal test results (T-scores<40, adjusted for age and 
education level) for Fatigued (Fatigue Severity Scale (FSS) ≥4) versus Non-Fatigued (FSS<4) pa-
tients with PM-SAH.
Fatigued 
n=15 
% abnormal
Non-Fatigued
n=31 
% abnormal
Fatigued vs  
Non-Fatigued  
p-value
D2, Concentration performance 28.6 0.0 0.007
D2, Total performance 50.0 6.5 0.002#
Digit Span, Total score 20.0 6.5 0.311
15 WT, Total score 33.3 9.7 0.092
15 WT, Total recall 33.3 12.9 0.127
15 WT, Total recognition 6.7 6.5 0.704
Rey Complex Figure, Copy score 20.0 9.7 0.375
Rey Complex Figure, Recall score 46.7 22.6 0.170
Symbol Substitution, Total good 20.0 0.0 0.030
TMT-A (max. 180 sec.) 33.3 0.0 0.002#
TMT-B (max. 180 sec.) 20.0 6.5 0.311
Tower Test, Total performance 13.3 0.0 0.101
WF, Semantic (1 min.) 26.7 12.9 0.414
WF, Phonological 26.7 23.3 1.000
15 WT: 15 Words Task; TMT: Trail Making Test; WF: Word Fluency.
Missings: D2: n=1; Tower Test: n=1
# Significant after Bonferroni correction (p<0.003)
Comparison between fatigued and non-fatigued patients and norms
Patients with fatigue did not differ significantly from patients without fatigue in subjective 
cognitive functioning, but they did have significantly poorer scores on the objective 
cognitive functioning domains of attention and concentration, speed of information 
processing, and memory (Table II). 
Comparing the T-scores, which were adjusted for age and education level, we found that 
the proportion of patients with abnormal test results was significantly larger in the fatigued 
group than in the non-fatigued group for the D2 Concentration performance, D2 Total 
performance, TMT-A and SS (Table III). 
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Further, in the fatigued group, total mean scores on TMT-A (t=2.3; p=0.023) in the speed 
of information processing domain, TMT-B (t=3.3; p=0.002) in the executive functioning 
domain, and CFQ (t=3.6; p<0.001) in subjective cognitive functioning were significantly 
worse than those from healthy individuals.22
Relationships between fatigue, depression, comorbidity and cognitive functioning
In Table IV the correlations between fatigue, subjective and objective cognitive functioning, 
depression and comorbidity scores are presented. Strong correlations were found among 
fatigue, depression, and comorbidity. Higher fatigue scores were related to poorer cognitive 
functioning on all domains (subjective and objective), except for visuoconstruction. 
Depression score was associated with poorer scores of subjective cognitive functioning, 
attention and concentration, and memory. Comorbidity score was negatively associated 
with the domains of processing speed, attention and concentration, and memory. Subjective 
cognitive functioning (CFQ) was not associated with any domain of objective cognitive 
functioning. Partial correlations showed that the relationships between fatigue and Digit 
Span (forward) (p=0.032), Symbol Substitution (total good) (p=0.041), 15WT (total score) 
(p=0.041), Word Fluency (semantic) (p=0.021) and Word Fluency (phonological) (p=0.011) 
remained significant, adjusted for depression. These variables still covered all the domains 
of objective cognitive functioning, except the domain visuoconstruction. Adjusting for 
both depression and comorbidity, revealed that relationships between fatigue and Digit 
Span (forward) (p=0.019) and Word Fluency (phonological) (p=0.010) remained significant.
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table iV. Pearson correlations between fatigue, subjective and objective cognitive test 
outcomes, depression score, and comorbidity score.
FSS 
total score
p-value
HADS 
Depression
p-value
CiRS 
total score
CFQ 
total score
p-value
FSS, Total score 1 0.597 (<0.001) 0.473 (0.001) 0.405 (0.005)
HADS, Depression 0.597 (<0.001) 1 0.419 (0.004) 0.372 (0.011)
CIRS, Total score 0.473 (0.001) 0.419 (0.004) 1 -
Subjective cognitive functioning
CFQ, Total score 0.405 (0.005) 0.372 (0.011) - 1
Attention and concentration
D2, Concentration performance -0.351 (0.018) - -0.371 (0.012) -
Digit Span, Forward -0.545 (<0.001)*‡ -0.353 (0.016) - -
Speed of information processing
D2, Total performance -0.326 (0.029) - -0.387 (0.009) -
TMT-A (max. 180 sec.) 0.369 (0.012) - - -
Symbol Substitution (Total good) -0.454 (0.002)* - -0.413 (0.004) -
Memory
15 WT, Total score -0.408 (0.005) -0.383 (0.009) -0.334 (0.023) -
15 WT, Total recognition -0.314 (0.034) -0.427 (0.003) -0.467 (0.001) -
15 WT, Total recall -0.410 (0.005) -0.327 (0.026) -0.324 (0.028) -
Rey Complex Figure, Recall score -0.399 (0.006) - - -
WF, Semantic -0.371 (0.011) - -0.406 (0.005) -
Digit Span, Backwards -0.335 (0.023)* - - -
Digit Span, Total score -0.476 (0.001) -0.352 (0.017) - -
Executive functioning
Tower Test, Total performance -0.368 (0.017) - - -
WF, Phonological -0.453 (0.002)*‡ - - -
TMT-B (max. 180 sec.) - - - -
Visuoconstruction
Rey Complex Figure, Copy score - - - -
CFQ: Cognitive Failure Questionnaire; TMT: Trail Making Test; 15 WT: 15 Words Task; WF: Word Fluency; 
FSS: Fatigue Severity Scale; CIRS: Cumulative Illness Rating Scale; HADS: Hospital Anxiety and Depression Scale.
* Significant partial correlations adjusted for depression p<0.05
‡ Significant partial correlations adjusted for depression and comorbidity p<0.05
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DiSCUSSioN
The main finding in this study was that 1 in every 3 patients suffered from fatigue in the long 
term after onset of PM-SAH. Fatigue was strongly related to poorer scores on both subjective 
and objective cognitive functioning, depression, and comorbidity. Higher depression and 
comorbidity scores were also related to reduced objective cognitive functioning. However, 
only fatigue was associated with the domain of executive functioning, also after adjustment 
for depression and comorbidity. This is in line with the results from our previous study.3 
Fatigue after A-SAH is often described in the literature. The review of Kutlubaev et al. 
(2012) mentioned pituitary dysfunction as a potential predictor for post A-SAH fatigue. 
Also relationships between fatigue and factors like anxiety, depression, PTSD, memory 
difficulties, personality changes, sleep disturbances and cognitive and physical impairment 
after A-SAH are described.28,29 In this study, relationships of fatigue with cognitive functioning 
and depression are also found in PM-SAH patients. Pihlaja et al. (2014) presented similar 
associations of fatigue with negative cognitive outcomes, and lower rates of return to 
work 3-6 months after stroke.30 The employment rate of patients with fatigue in our 
study was relatively low (40.0%) compared to patients without fatigue (74.2%), although 
not significantly different. The total employment rate in patients with PM-SAH (63.0%) 
was comparable to the return-to-work rate after A-SAH (61.4%), despite the presumed 
favourable outcome.31
Comparing the proportions of abnormal test scores between the fatigued and non-fatigued 
group we found significant differences in subjective cognitive functioning, attention 
and concentration, and speed of information processing. Furthermore, patients with 
fatigue experienced more subjective cognitive complaints and underperformed healthy 
individuals on the TMT-A and TMT-B tasks for speed of information processing, and executive 
functioning.15,22 These results support the findings from our previous work in a relatively 
small group of patients with PM-SAH (n=8), in which fatigue and executive functioning were 
affected.3 Krajewski et al. (2013) also found tendencies of memory impairment and slower 
cognitive processing in PM-SAH groups 2 years after discharge, but found no significant 
differences compared with norm data.10 However, they did not perform subgroup analyses 
in patients with fatigue. 
Because of the good prognosis, in terms of no risk of re-bleeds and unaffected survival 
rates, patients with PM-SAH are mostly discharged home without follow-up. Moreover, 
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this group of patients is often excluded from scientific research, because of the assumed 
good prospects. The outcomes of our study questions this assumption. Patients with PM-
SAH could be followed in outpatient rehabilitation clinics to screen for problems of cognitive 
functioning, fatigue, and mood. There are simple screening questionnaires like the FSS and 
HADS available as a starting point for screening. Subjective cognitive functioning appeared 
not to be related to objective cognitive functioning.15 Our results suggest that screening 
for subjective cognitive problems using the CFQ may not be sufficient in detecting specific 
problems of cognitive functioning.
This study has some limitations. Despite the fact that with a larger number of patients we 
confirmed the results of our previous study, the sample size is still small. Also the absence 
of short-term measurements and follow-up measurements can be considered a limitation 
of this study, because no causal relationships could be studied. Furthermore, not all patients 
that were contacted responded or were interested in taking part in this study, which may 
have resulted in selection bias.
In conclusion, this study supports our findings from previous research that the consequences 
for patients with PM-SAH are underestimated. These patients may be left with fatigue, have 
less than optimal cognitive functioning, and relatively low employment rates. Patients with 
PM-SAH should be screened for these problems in outpatient clinics, just as patients with 
aneurysmal SAH. Future research should investigate whether these patients would benefit 
from long-term follow-up and/or rehabilitation programs incorporating fatigue management 
and/or cognitive rehabilitation.
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ABStRACt
objectives: The aim was to study changes over time for multiple outcomes based on the 
International Classification of Functioning, Disability, and Health in patients with aneurysmal 
subarachnoid haemorrhage and to compare long-term outcomes with norms.
Design: A prospective cohort study with 4-year follow-up was conducted. Main outcome 
measures were as follows: Center for Epidemiologic Studies Depression-Scale, Fatigue 
Severity Scale, Trail Making Test A and B, Barthel Index, Sickness Impact Profile-68, Impact 
on Participation and Autonomy Questionnaire, Social Support List-12, Multidimensional 
Health Locus of Control Scales, COOP-WONCA Charts, and Short Form-36 Health Survey.
Results: Seventy-six patients with aneurysmal subarachnoid haemorrhage were included. 
Measurements were done at T1=0.4 years (SD 0.3) and T2=3.9 years (SD 0.7) after onset. 
Significant improvements over time were found for Barthel Index (T1=18.5; T2=19.5; 
p=0.023), Trail Making Test B (T1=119.4; T2 = 104.6; p=0.025), Social Support List-12 total 
score (T1=31.1; T2=32.7; p=0.042) and esteem support (T1=10.2; T2=10.9; p=0.027), 
Multidimensional Health Locus of Control Scales (physician-orientation) (T1=21.8; T2=19.2; 
p=0.020), and Short Form-36 Health Survey (role-emotional) (T1=54.6; T2=73.9; p=0.048). 
Center for Epidemiologic Studies Depression Scale, Fatigue Severity Scale, Sickness Impact 
Profile-68, and Short Form-36 Health Survey scores remained stable over time. A decline 
was found for COOP-WONCA (overall-health) (T1=2.3; T2=2.7; p=0.021). At 4-year follow-up, 
proportions of depression (27%) and fatigue (60%) were larger and scores on the Fatigue 
Severity Scale (mean [SE], 4.3 [0.2]), Trail Making Test A (mean [SE], 51.3 [3.9]), and Trail 
Making Test B (mean [SE], 104.4 [0.2]) were significantly worse than norm scores.
Conclusions: Many patients with aneurysmal subarachnoid haemorrhage had fairly good 
long-term outcomes, but problems in executive functioning, mood, and fatigue still exist 
at long-term follow-up.
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iNtRoDUCtioN
Aneurysmal Subarachnoid Haemorrhage (A-SAH) accounts for 85% of all cases of 
subarachnoid haemorrhage (SAH). Compared with ischemic stroke, A-SAH occurs at a 
relatively young age, when patients are in the most productive stage of their life, in which 
work and family are important responsibilities.1,2 This is why even minor sequelae of A-SAH 
can have a major and long-lasting impact on quality of life.
Al-Khindi et al. (2010) showed that deficits in memory, executive functioning, and language 
are common after A-SAH and may persist until 2 to 3 years after onset. Furthermore, mental 
slowness and attention deficits are known long-term consequences of A-SAH.2,3 Patients 
who do regain independence for activities of daily life may not be able to resume work, 
experience difficulties in maintaining and establishing relationships, and report mood 
disturbances and impaired quality of life with long-term anxiety complaints, symptoms of 
depression, and fatigue.4-7
However, studies that evaluate the outcomes of SAH survivors beyond the horizon of 1 year 
after onset are scarce. Furthermore, most studies have a retrospective design and focus 
on single outcomes.8,9 Thus, prospective studies with long-term follow-up and evaluating 
multiple outcomes over time are lacking.
Therefore, a prospective study was designed to assess multiple outcomes for patients with 
A-SAH over a follow-up period of 4 years. Outcomes were evaluated based on all domains of 
the International Classification of Functioning, Disability, and Health (ICF) model and related 
to normative values. As such, an overview of long-term consequences of A-SAH was created, 
which may help rehabilitation services to adapt their programs to long-term needs.
mEtHoDS
Participants and Procedures
Patients were included if they were hospitalized between 2006 and 2009 at the neurology 
or neurosurgery department from the Erasmus University Medical Center Rotterdam with a 
diagnosis A-SAH determined by computed tomography, and if negative, by a lumbar puncture 
followed by a computed tomography angiography or digital subtraction angiography to 
detect the aneurysm.10 Other inclusion criteria were at least 18 years of age and survival of 
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A-SAH at least until hospital discharge. Exclusion criteria were neurologic comorbidity, serious 
comorbidity resulting in a life expectancy less than 1 year and insufficient knowledge of the 
Dutch language. Patients who agreed to participate were asked to sign an informed consent 
form. The study was approved by the Medical Ethics Committee of the Erasmus MC.
Data Collection
During hospitalization, baseline socio-demographic data and clinical characteristics were 
collected by the medical staff and prospectively entered into an anonymized database. The 
severity of the SAH is measured with the Glasgow Coma Scale and the World Federation 
of Neurosurgical Societies classification. Glasgow Coma Scale scores range from 3 to 15, 
where higher scores represent a higher level of consciousness, and World Federation of 
Neurosurgical Societies scores range from 1 (no symptoms) to 5 (severe symptoms).11 
Within 6 months after onset (T1), a research psychologist assessed the patients at home. To 
investigate long-term outcomes, a revisit was performed by a trained research psychologist 
4 years after onset (T2).
Measurement Instruments and ICF Model
The measurement instruments in this research are categorized within the domains of the 
ICF model displayed in Figure 1. The extra category in the model is Health-Related Quality 
of Life (HR-QoL) as described in the review of Passier et al. (2013).12
Body Functions and Structures
The ICF domain body functions and structures refers to anatomical parts and physiologic 
functions of body systems and covers SAH characteristics, such as fatigue, mood, and 
neuropsychological impairments.12,13 Within this domain, the study focused on cognition 
and mood. The Center for Epidemiologic Studies Depression scale (CES-D) is used to measure 
depressive symptoms over the previous week using a 20-item scale. This scale is validated 
in stroke patients. Scores range from 0 to 60, and the higher the score, the more depressive 
symptoms are present. Scores of 16 or higher are indicative of the presence of depression.14 
The Fatigue Severity Scale (FSS) measures fatigue by means of nine statements that must 
be scored on a 7-point Likert scale ranging from 1, “strongly disagree”, to 7, “strongly agree”. 
Mean scores of 4 or higher out of 9 are outside the range of healthy controls.15 The Trail 
Making Test (TMT) parts A and B are sensitive to a wide range of neurocognitive deficits. 
Part A measures motor speed and processing speed, and part B measures processing speed 
and divided attention. The total time (with a maximum of 180 sec.) is recorded and includes 
the extra time for correcting potential errors.16
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Activities
The ICF domain activities represents the execution of tasks or actions by an individual.13 
The Barthel Index (BI) is used to evaluate the patient’s state of independence in activities of 
daily living, with total scores ranging from 0 to 20, in which 0 means completely dependent 
and 20 means completely independent.17 The Sickness Impact Profile-68 (SIP-68) measures 
physical, mental, and social aspects of health-related functioning in six subscales: somatic 
autonomy, mobility control, mobility range, social behaviour, emotional stability, and 
psychological autonomy/communication. It contains 68 dichotomous (yes/no) items. The 
items reported as yes are used to calculate the total score. Higher scores indicate more 
health-related behavioural problems.18
Participation
The ICF domain participation refers to involvement in life situations, like return to work, 
social roles, and family life.12 Participation was measured only at long-term follow-up (T2) 
using the Impact on Participation and Autonomy (IPA) and a description of the patients’ work 
status, for patients who were younger than 65 years at the moment of the measurement. 
The IPA measures constraints in participation and autonomy. The questionnaire consists 
of 41 items divided over eight subscales: self-care and appearance, mobility, leisure, social 
relationships, work, education, family role, and financial independence. Each item was 
scored on a 5-point rating scale, ranging from 1 (excellent) to 5 (very poor). A higher sum 
score on a subscale indicates a greater perceived handicap on this specific subscale.19
Environmental Factors
Environmental factors are external features of physical, social and attitudinal environment 
in which people live and conduct their lives.13 In this domain, the Social Support List (SSL-
12) was used. This questionnaire measures the extent of received social support by means 
of social interactions with members of the primary social network. The questionnaire 
consists of 12 questions, which all start with “Does it ever happen to you that people…” 
The patient must answer the questions by choosing one of four options: (1) seldom or 
never, (2) now and then, (3) regularly, and (4) very often. Three subscores, everyday support, 
support in problem situations, and esteem support, and the total score can be calculated 
by the sum of the corresponding items. High scores indicate a high level of social support 
on the corresponding (sub)score.20
Personal Factors
Personal factors are features that can have impact on an individual’s performance.12 For this 
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domain, the Multidimensional Health Locus of Control Scale (MHLCS) is used. The MHLCS 
measures the degree to which people perceive them-selves as having control over their 
own health. The scale consists of three dimensions: internal (the extent to which individuals 
perceive their own behaviour as responsible for their health), physician (the extent to which 
individuals perceive their physician as responsible for their health), and chance (the extent 
to which individuals perceive luck, fate, or chance as responsible for their health). Each 
subscale consists of six items with a 6-point Likert-type scale, ranging from “completely 
agree” to “completely disagree”. For each subscale, a total score is computed, with high 
scores indicating strong orientations.21
Health-Related Quality of Life
HR-QoL is not an official category of the ICF but an important concept to study in relation 
to SAH.12 Questionnaires linked to the concept HR-QoL are the Short Form-36 Health 
Survey (SF-36) and the COOP-WONCA Charts. The SF-36 measures perceived health and 
contains 36 items in eight health-related domains: physical functioning, physical role, 
bodily pain, general health, vitality, social functioning, emotional role, and mental health. 
The scores range from 0 to 100. Zero represents the worst imaginable health state, and 
a score of 100 represents perfect health.22 The COOP-WONCA Charts is a measure for the 
patients’ assessment of his/her functional capacity at the given time. This scale consists of 
seven aspects of functional status: physical fitness, feelings, daily activities, social activities, 
change in health, overall health, and pain. The scores range from 1 to 5. Mean scores per 
aspect of functional status are calculated, and higher scores on an aspect indicate a more 
affected HR-QoL on that specific subject.23
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics version 21 (SPSS Inc, Chicago, 
USA). Descriptive statistics were used to describe the patient and clinical characteristics 
of the total group and subpopulations of T1 and T2. Linear mixed-model analyses were 
performed to study changes over time for each outcome, in which the covariance between 
measurements within patients is taken into account. This method is very flexible in 
handling missing values. Time was entered in each model as a predictor of the outcomes. 
A significance level of p<0.05 was used in all analyses. Comparisons of the long-term 
outcomes (T2) of the A-SAH group with norm values of healthy subjects were performed, by 
calculating Z-scores using the standard deviation of the norm group. A positive or negative 
Z-score indicates how many standard deviations the patient’s score deviates from the norm 
in positive or negative direction. A Z-score of 1.96 or higher is significantly different from 
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• Declined (n=23)
• Missed (n=22)
• Died (n=4)
Total SAH (n=228)
T1 Completed: (n=59) 
• Missed (n=17)
A-SAH Assessed for 
eligibility (n=125)
Included (n=76)
Excluded (n=103)
• Died (n=63)
• Comorbidity (n=13)
• Non Dutch (n=7)
• No aneurysm (n=20)
T2 Completed: (n=60) 
• Died (n=1)
• Declined (n=10)
• Lost to follow-up (n=5)
healthy individuals. P-values were also calculated using independent-samples t-tests for 
interval variables and Fisher’s exact tests for categorical variables, using a statistical internet 
tool (GraphPad Software Inc, La Jolla, CA). Norm scores of healthy individuals were obtained 
from the literature.14-16,21-24
RESULtS
Study Population
A total of 76 patients diagnosed with A-SAH agreed to participate in this study. One patient, 
in whom no aneurysm was found, was included in the study because this patient had an 
aneurysmal pattern of haemorrhage. The flow of patients is shown in Figure 2. A total of 
76 patients were included, of which 59 completed T1 and 60 completed T2; the number of 
patients who completed both T1 and T2 was 43. The mean age of the total group was 53.8 
years, and 31.6% were men. Twenty-five percent of the patients were treated in an inpatient 
or outpatient rehabilitation facility, and 14.4%, in a nursing home. The patient and SAH 
characteristics of the 76 patients are presented in Table I.
CHAPTER 4
Figure 2. Flowchart of patient inclusion procedure.
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total A-SAH patients t1 (n=59) t2 (n=60)
Age, years 53.8 ± 11.5 53.6 ± 11.7 53.2 ± 10.9
Gender, men 24 (31.6) 19 (32.2) 22 (36.7)
Partner, yes 52 (68.4) 44 (74.6) 42 (70.0)
Education, high 14 (18.4) 10 (16.9) 14 (23.3)
Smoking, yes 32 (42.1) 25 (42.4) 28 (46.7)
Alcohol use, daily 17 (22.4) 12 (20.3) 19 (31.7)
Hypertension, yes 30 (39.5) 26 (44.1) 30 (51.7)
Employed, before SAH - 34 (70.8) -
Employed, after SAH - - 17 (31.5)
Length of Hospital stay, days 17.4 ± 10.5 16.4 ± 9.8 17.0 ± 10.3
GSC score at hospitalization 12.7 ± 3.7 13.0 ± 3.5 12.7 ± 3.8
WFNS grade at hospitalization
   Grade 1 39 (51.3) 31 (52.5) 31 (51.7)
   Grade 2 16 (21.1) 12 (20.3) 13 (21.7)
   Grade 3 3 (3.9) 3 (5.1) 3 (5.0)
   Grade 4 8 (10.5) 7 (11.9) 5 (8.3)
   Grade 5 10 (13.2) 6 (10.2) 8 (13.3)
Location of aneurysm, anterior 48 (66.7) 38 (67.9) 39 (68.4)
Treatment of aneurysm
   Clipping 21 (27.6) 17 (28.8) 15 (25.0)
   Coiling 51 (67.1) 39 (66.1) 41 (68.3)
Hospital discharge destination
   Discharge home 46 (60.5) 36 (61.0) 34 (56.7)
   Outpatient rehabilitation 8 (10.5) 7 (11.9) 9 (15.0)
   Inpatient rehabilitation 11 (14.5) 7 (11.9) 14 (23.3)
   Nursing home 11 (14.4) 9 (15.2) 3 (5)
Time post-onset, years - 0.4 ± 0.3 3.9 ± 0.7
Data are presented as mean ± SD or n (%).
Missing data: hypertension, n=2; location of aneurysm, n=4; employed before SAH <65 years, n=11; 
employed after SAH >65 years, n=6. 
IQR indicates interquartile range; GCS, Glasgow Coma Scale; WFNS, World Federation of Neurosurgical 
Societies classification.
table i. Patient and clinical characteristics (N=76).
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Changes over Time
All data of T1 and T2 were analysed to estimate the mean outcomes for the two measurement 
times, which are presented in Table II. Significant improvements were found in the domain body 
functions and structures for TMT-B (T1=119.4; T2=104.6; p=0.025), in the domain activities for BI 
(T1=18.5; T2=19.5; p=0.023), in the domain environmental factors for SSL-12 (T1=31.1; T2=32.7; 
p=0.042), and in the domain personal factors for MHLCS (physician-orientation) (T1=21.8; 
T2=19.2; p=0.020). For HR-QoL, the COOP-WONCA (overall health) (T1=2.3; T2=2.7; p=0.021) 
showed a significant decline, and the SF-36 (role limitation due to emotional problems) (T1=54.6; 
T2=73.9; p=0.048) showed a significant improvement. Scores on the CES-D, FSS, SIP-68, and the 
remaining scores on the COOP-WONCA and SF-36 remained relatively stable over time.
Comparison of A-SAH Outcomes with Norm Values
Compared with norm scores of healthy individuals, clinically significant differences were found 
for FSS, TMT-A, and TMT-B scores in patients with A-SAH at 4-year follow-up (T2). The patients 
showed higher fatigue scores and needed significantly more time to complete the TMT-A and 
TMT-B tasks than did healthy individuals within their age group. The proportions of depressed 
and fatigued patients with A-SAH also were significantly higher than in healthy groups (Table 
III). The variables in the domain personal factors showed no significant differences compared 
with the norm scores. Also, the outcomes for the domain HR-QoL were not significantly 
different from the norm scores, but the outcomes in Table III showed a trend toward worse 
outcomes for patients with A-SAH compared with the norm scores in almost all subscales of 
HR-QoL. Norm scores of healthy individuals were found neither for BI and SIP-68 in the ICF 
domain activities nor for the IPA in the domain participation. For the BI, it was assumed healthy 
people to reach the maximum score of 20. With a mean BI score of 19.5, some restrictions in 
activities of daily living were found 4 years after A-SAH. Twenty-five percent of the patients 
with A-SAH did not reach the maximum score of 20; some problems were found in the activity 
of climbing stairs (13%) and some suffered from occasional urine incontinence (15%). In the 
same domain, the mean SIP-68 score was significantly different from zero (p<0.001), the score 
assumed for healthy subjects.23 Eighty-two percent of the patients experienced one or more 
problems at the SIP-68. The highest percentages of patients with problems were found in the 
subdomains psychological autonomy and communication (60%) and social behaviour (62%).
IPA scores were relatively low, varying from 0.6 [SE 0.7] to 1.6 [SE 0.7], indicating reasonable to 
good participation. Employment proportions were 71% before A-SAH, which is comparable 
with the total Dutch population of working age (15-65 years). Four years after A-SAH, 34% 
of the patients younger than 65 years were employed (Tables I and III).
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DiSCUSSioN
Improvement was found in at least one outcome in every measured ICF domain in this 
long-term prospective study of patients with A-SAH. Although improvement was found for 
the executive functioning task TMT-B, patients with A-SAH needed significantly more time 
to complete this task than norms of healthy individuals. TMT-A score was stable for T1 and 
T2 but also significantly worse compared with the norms. This outcome also applied for 
fatigue, where no improvement was found in the long-term, with scores above the norm 
scores and the cut-off score. Depression scores showed no significant improvement over 
time and no differences with a healthy norm group in the long term.
However, the proportion of depressed patients was significantly higher than in a healthy 
population.14 This means that a relatively large number of patients with A-SAH experience 
fatigue, depressive symptoms, and problems in cognitive functioning, which may persist 
over the years. These problems are also found separately in other studies.2,25,26 Whether 
rehabilitation professionals can adapt their programs to the long-term needs of these 
patients remains to be investigated. In this study, approximately one-third of the sample 
were treated in an inpatient rehabilitation centre or nursing home.
The BI showed significant improvement over time but is too rough a measure to detect small 
problems and suffers from a ceiling effect, especially in long-term outcome measurement.2 
Other measurement instruments, such as the Functional Independence Measure and 
the Functional Assessment Measure, may have been more specific.27 In this study, some 
problems were found in the activity of climbing stairs and occasional problems of urine 
incontinence at long-term follow-up. Whether these problems were related to the SAH 
remains unknown. The SIP-68 is more sensitive for health-related behavioural problems 
in the long term.27 Although patients with A-SAH had significantly worse scores than 
healthy individuals, they had better scores than patients with ischemic stroke.18 In 25% of 
the patients, some problems in self-care (BI) were found in A-SAH patients, but in 82%, 
behavioural difficulties were found for more specific tasks (SIP-68) in the long run, such as 
psychological autonomy and communication and social behaviour.
In this study, 69% of the patients younger than 65 years were not working in the long-
term after the A-SAH, which is a large proportion compared with the Dutch population of 
working age (28.4%).24 Vilkki et al. (2012) found 56.4% of patients with A-SAH not working 
in the long term after the haemorrhage, of which 20% ascribed this to their SAH.28 They 
CH
A
Pt
ER
 4
64
also found a higher age as the most important long-term predictor for a poor work status 
after A-SAH.28 In Passier et al. (2011), 1.4% of the subjects returned to work after A-SAH, 
of which only 35.2% completely resumed their previous position.29 Cognitive functioning/
attention and fatigue are known predictors of work status.25,28,29 The long-term IPA-scores 
in this study were higher than zero, especially for the variables ‘autonomy outdoors’ and 
‘work and education’. However, the mean scores were all relatively low, representing the 
categories between good and reasonable. Thus, patients in this study sample did perceive 
some limitations in autonomy and participation but scored within normal ranges.
The physician-oriented locus of control scale showed a decline over time, representing a 
decreased attribution of one’s health status to the physician. Either the patient’s health 
status has improved or he/she has learned to cope with the long-term sequelae of the 
A-SAH. No differences were found on the locus of control scales compared with healthy 
individuals. In the domain environmental factors, an improvement in the experience of 
social support was found, especially in the esteem support domain, which implies that self-
esteem and approval are improved by the support of others.20
Finally, a significant improvement in HR-QoL was found in the SF-36 domain role limitations 
due to emotional problems and a decrease for overall health on the COOP-WONCA charts. 
Compared with norm scores, no significant differences were found for HR-QoL in the long 
term, but a trend toward decreased HR-QoL scores can be seen in almost all domains compared 
with normative data. The findings in the literature are also mixed. Scharbrodt et al. (2009) 
found lower HR-QoL in the long term for patients with SAH, but Greebe et al. (2010) found an 
improved HR-QoL between 5 and 12.5 years after A-SAH, which may be due to psychological 
adaptation.30,31 Another plausible explanation for these differences can be the differences in 
case mix. Al-Khindi et al. (2010) describes severity of A-SAH at hospital admission, depression, 
anxiety, fatigue, neuroticism, and a passive coping style as factors that could influence HR-QoL 
after A-SAH.2
Limitations
This study has some limitations. The moment of T1 was variable and covering a phase in 
which spontaneous recovery is an important factor. Participation was measured only at 
T2. No data were available for the premorbid situation or at T1. However, despite missing 
data, the mean outcomes of the total study population could be reliably estimated by using 
mixed-model analyses. Finally, a limited number of questionnaires was used to cover all 
domains of the ICF model. Other studies could have used other questionnaires to describe 
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the ICF domains and possibly found other results per domain. The original ICF model has no 
specific domain for HR-QoL. According to Passier et al. (2013) the ICF model was therefore 
expanded, with HR-QoL as an additional domain to include outcomes of HR-QoL after 
A-SAH.12,32
CoNCLUSioNS
Despite the fact that many patients with A-SAH had fairly good long-term outcomes, 
problems in executive functioning, depression, and fatigue still exist at long-term follow-
up. Whether rehabilitation services can adapt their programs to long-term needs of these 
patients should be studied in future research.
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ABStRACt
objective: To assess long-term unmet needs in relation to community integration and 
employment status 4 years after subarachnoid haemorrhage (SAH). 
Design: Four-year follow-up of a prospective cohort.
Patients: Sixty-seven patients with SAH.
methods: Employment status was assessed and the Community Integration Questionnaire-
Revised and Southampton Needs Assessment Questionnaire were used.
Results: The mean age of SAH onset was 52.5 years (SD 10.7) and 39% were men. Four 
years after SAH, 23.9% had symptoms of depression, 43.3% had mild cognitive impairment, 
67.2% was unemployed and 67.2% had one or more unmet needs. The need for information 
was mostly reported (59.7%). Unemployed patients had more unmet needs than employed 
patients (p=0.034), but no independent relationship was found. The community integration 
score was moderate (mean=15.1; SD=4.4). A higher level of unmet needs was independently 
related to a lower level of community integration (B=-0.25; p=0.018), adjusted for age and 
comorbidity. 
Conclusion: The results of this study show a large proportion of patients with unmet needs 
and without employment 4 years after SAH, and also an inverse relation between unmet 
needs and community integration. Future research should investigate whether dealing 
with information needs during rehabilitation contributes to better community integration 
in these patients.
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iNtRoDUCtioN
 
Subarachnoid haemorrhage (SAH) accounts for 5% of all cases of stroke and is in 
approximately 85% of cases caused by a ruptured aneurysm in one of the cerebral vessels, 
called aneurysmal subarachnoid haemorrhage (A-SAH). In about 10% of the cases no 
aneurysm is found, and the haemorrhage is restricted to the cisterns surrounding the 
brainstem and the suprasellar cistern; called perimesencepahlic subarachnoid haemorrhage 
(PM-SAH). The remaining 5% is categorized as SAH of unknown origin.
After SAH, patients may face long-term impairments, like fatigue, cognitive disorders, mood 
disturbances and reduced quality of life.3-7 The mean age of SAH onset is 50 years, which is 
relatively low compared to the other types of stroke which show a mean age of onset of 75 
years.8 Therefore, SAH may have a long-lasting and profound impact on social participation 
including return to work.9,10 Several studies have addressed return to work (RTW) after SAH. 
The studies of Passier et al. (2011) and Harris et al. (2014) found that approximately 40% 
of the patients with A-SAH (n=141 and n=134) did not return to work 1 to 4 years after 
A-SAH.10,11 Alfieri et al. (2011) found that more than 10% of the patients with non-aneurysmal 
SAH (a group without objective impairment) did not return to work 7 years after SAH.12 RTW 
up to 8 years after different types of SAH was found to be related to marital status, age and 
depression.10-12 In young stroke patients (mean age 55 years), Kersten et al. (2002) found 
that people unable to return to work and those with poorer mobility report most unmet 
needs.13
RTW is only one aspect of community integration. Community integration is described 
as participation in home, social and community activities.14 Not much is known about 
community integration in patients with SAH. A recent study of Buunk et al. (2015) showed 
that resumption of previous leisure and social activities is seriously impaired 4 to 10 
years after A-SAH. The presence of executive, cognitive and emotional problems, just as 
unemployment are associated with this outcome.15 Also the study (n=10) by Ravnik et al. 
(2006) found that cognitive impairment, but also RTW were related to the level of community 
integration after SAH.7 Whether patients with SAH face unmet needs in relation to RTW and 
community integration has not been studied before. SAH should be considered a lifelong 
condition rather than an incident. Therefore, more effort should be invested in optimizing 
long-term outcome, minimizing unmet needs and maximizing community integration.
UNMET NEEDS AND COMMUNITy INTEGRATION 4 yEARS AFTER SAH
CH
A
Pt
ER
 5
74
The current study therefore focused on long-term outcome after SAH (4 years post-onset) 
with community integration, employment status, and the presence of unmet needs as 
outcomes of interest. The aim of this study was to evaluate whether patients face unmet 
needs 4 years after SAH onset, and whether these unmet needs are related to community 
integration and/or employment status.
mEtHoDS
Participants and Procedures
All patients diagnosed with SAH, hospitalized between 2006 and 2009 at the neurology 
and neurosurgery department from the Erasmus University Medical Center Rotterdam, 
were approached for participation in a prospective cohort study with measurements 
within 1 and 4 years post-onset.16 The current study focuses on the long-term outcome 
of this cohort. Inclusion criteria were: at least 18 years of age at onset and survival of SAH. 
Exclusion criteria were: serious comorbidity resulting in a short life expectancy less than 1 
year and insufficient mastering of the Dutch language. Informed consent was obtained from 
all participants. The Medical Ethics Committee of the Erasmus MC approved the study.
Data collection
During hospitalization baseline socio-demographic data and clinical characteristics were 
collected by the staff of the neurology and neurosurgery departments, including origin 
of SAH and severity of SAH using the World Federation of Neurological Surgeons (WFNS) 
grading scale. A trained research psychologist visited the patients at home to collect 
additional measurements 4 years post-onset. A structured interview was performed to 
collect data on current employment status. Patients were classified as employed if they had 
a paid full-time or part-time job. Patients were defined as not employed if they did not have 
a paid job, only performed unpaid volunteer work, were students, or were retired.
Measurement instruments
The Community Integration Questionnaire (CIQ) measures community integration based 
on three subscales: Home competency, Social integration, and Productivity activity. We 
used the revisited CIQ scale with 13 questions based on the article of Sander et al. (1999).17 
Each question was scored on a three-point rating scale ranging from 0 to 2, with a total 
score range of 0-25. A high score indicates a high level of community integration.17,18 The 
CIQ was originally developed for patients with traumatic brain injury, but the psychometric 
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properties have also been evaluated in stroke patients with aphasia. The internal consistency 
(Cronbach’s α=0.75) is good, and the test-retest reliability (Intraclass Correlation coefficient 
=0.96) is excellent.19
The summary section of the Southampton Needs Assessment Questionnaire (SNAQ) was 
used to assess the unmet needs of patients after SAH. Patients fill in which unmet need they 
face in dealing with the consequences of their SAH. The SNAQ consist of 66 items divided 
over 10 domains (information, mobility, social activities, work or training, family, voluntary 
organizations, finances, housing, formal health services, formal social services). Possible 
responses are yes (score 1) and no/not applicable (score 0). A total score is calculated. Higher 
scores indicate more unmet needs. The questionnaire is validated in a group of disabled 
people including patients with stroke.20 
The Center for Epidemiological Studies Depression scale (CES-D) was used to measure 
symptoms of depression. The CES-D is a 20-item scale, and is validated in stroke patients.21 
Scores range from 0 to 60 and the higher the score, the more depressive symptoms are 
present. Scores of 16 or higher are an indication for the presence of depression.21-23
Comorbidity was measured with the Cumulative Illness Rating Scale (CIRS). This list consists 
of 14 disorders and diseases, rated on a 5 point rating scale, ranging from 0 (disorder/disease 
not present) to 4 (life-threatening disorder/disease present).24 
The Coping Inventory for Stressful Situations (CISS) measures multidimensional coping, by 
asking the respondents how they generally react to stressful situations. The CISS exists of 
48 items which can be answered on a 5-point scale from not at all to very strong. Scores can 
be calculated for three scales, each existing of 16 items with a maximum score of 80: task-
oriented coping, emotion-oriented coping and avoidance-oriented coping.25
The Montreal Cognitive Assessment (MoCA) was used to screen for cognitive 
dysfunction. It contains 11 tasks focused on the different domains of attention and 
concentration, executive functions, memory, language, visuoconstructional skills, 
conceptual thinking, calculations, and orientation. The maximum attainable score is 30 
with a cut-off score of >26 considered as normal.26 The following ranges may be used to 
grade severity: 18-26 = mild cognitive impairment, 10-17 = moderate cognitive impairment 
and less than 10 = severe cognitive impairment.27
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The Trail Making Test (TMT), was used to measure cognitive functioning on the domains 
speed of information processing (part A) and divided attention (part B). The measured time 
to complete the task (with a maximum of 180 seconds), including extra time for correcting 
potential errors, was recorded to calculate a time score.28
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics version 21 (SPSS Inc, Chicago, 
USA). Descriptive statistics were used to describe the characteristics of the total study sample 
and subgroups of employed and unemployed patients. Means and standard deviations were 
calculated for interval variables and numbers and percentages for categorical variables. 
Independent-samples t-tests and χ2 were used to test differences between the employed 
and the unemployed subgroups. 
To investigate relationships between patient characteristics (age, gender, living with 
a partner, and education), clinical characteristics (SAH type, Length of Stay, and WFNS 
grade) and outcome variables (CIRS, CES-D, MoCA, CISS and SNAQ) with the dependent 
variable community integration (CIQ), univariable and multivariable regression analysis 
were performed. To investigate the same variables in relation to the dichotomous variable 
employment status, univariable and multivariable logistic regression analyses were 
performed. A significance level of p<0.05 was used to select variables from the univariable 
regression analyses, which were entered in the multivariable regression models using a 
forward selection procedure.
RESULtS
Study population
A total of 96 out of 228 consecutive patients with SAH, who were hospitalized in the 
neurology and neurosurgery departments of the Erasmus MC between April 2006 and 
August 2009 agreed to participate in the study. Of these, 67 patients participated in the 
4-years follow-up measurement with a mean time of 3.9 (SD 0.8) years after SAH. The 
flow of patients is presented in Figure. 1. Three patients were excluded for the long-term 
follow-up for the following reasons: 1 patient did not comprehend the questionnaires, 
1 patient moved abroad, and 1 patient recently had a recurrent stroke. Five patients were 
untraceable or could not be contacted and were considered lost to follow-up.
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The mean age of the study population was 52.5 years (SD 10.7) and 39% were men. The 
majority of patients had an aneurysmal SAH (88%), and 23.9% was classified with a poor 
WFNS grade (grade 3-5). Patient characteristics for the total and subgroups are presented 
in Table I. Four years after SAH, 67.2% of the sample was unemployed. The subgroup of 
unemployed patients contained significantly more women, were older, had less years of 
education, had a longer length of hospital stay, and more surgical procedures compared to 
employed patients (Table I).
• Declined (n=23)
• Missed (n=22)
• Died (n=4)
Total SAH (n=228)
Complete long-term 
follow-up (n=67)
SAH Assessed for 
eligibility (n=145)
Included (n=96)
• Died (n=63)
• Comorbidity (n=13)
• Non Dutch (n=7)
• Died (n=5)
• Declined (n=16)
• Lost to follow-up (n=5)
• Excluded (n=3)
Figure 1. Flow of patient inclusion.
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total group
67 (100%)
N%
Employed 
22 (32.8%)
n%
Unemployed  
45 (67.2%)
n%
Age (years), mean ± SD 52.5 ± 10.7 45.0 ± 8.8 56.2 ± 9.6*
Gender (men) 26 (38.8) 14 (63.6) 12 (26.7)*
Living together with a partner (yes) 48 (71.6) 17 (77.3) 31 (68.9)
Education (years) 12.9 ± 3.9 14.4 ± 3.6 12.2 ± 3.8*
Employed before SAH (n=56) 37 (63.8) 15 (83.3) 22 (57.9)
SAH type (aneurysmal) 59 (88.1) 17 (77.3) 42 (93.3)
Length of hospital stay (days), mean ± SD 15.7 ± 10.4 10.9 ± 6.0 18.1 ± 11.3*
Severity of SAH (WFNS)
   Grade 1 36 (53.7) 15 (68.2) 21 (46.7)
   Grade 2 15 (22.4) 4 (18.2) 11 (24.4)
   Grade 3 3 (4.5) 1 (4.5) 2 (4.4)
   Grade 4 5 (7.5) 0 (0.0) 5 (11.1)
   Grade 5 8 (11.9) 2 (9.1) 6 (13.3)
SAH treatment *
   Coiling 41 (61.2) 13 (59.1) 28 (63.6)
   Clipping 15 (22.4) 3 (13.6) 12 (27.3)
   Other 2 (3.0) 0 (0.0) 2 (4.5)
   No treatment 8 (11.9) 6 (27.3) 2 (4.5)
Discharge destination
   Home 40 (59.7) 17 (77.3) 23 (51.1)
   Outpatient rehabilitation 10 (14.9) 3 (13.6) 7 (15.6)
   Inpatient rehabilitation 14 (20.9) 2 (9.1) 12 (26.7)
   Nursing home 3 (4.5) 0 (0.0) 3 (6.6)
SAH: Subarachnoid Haemorrhage; WFNS: World Federation of Neurosurgical Societies; CIRS: Cumulative 
Illness Rating Scale. Missings: Employed before SAH, n=11
* Significant difference between employed and unemployed subgroups (p<0.05)
table i. Demographic and clinical patient characteristics for employed and unemployed 
patients (N=67).
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Unmet Needs
Two-thirds of the patients (67.2%) experienced one or more unmet needs 4 years after SAH, 
with a mean number of unmet needs of 3.5 (SD 4.7). The unmet needs were divided into 10 
domains, with the highest proportions of patients with unmet needs found in the domains 
information (59.7%), formal social services (20.9%), and mobility (19.4%). The proportions 
for each domain are presented in Figure 2.
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Figure 2. Proportions of patients with unmet needs for each domain.
Differences in outcome between employed and unemployed patients
After 4 years, depression was found in 23.9% and (mild) cognitive impairment in 43.3% of the 
total study sample. Unemployed patients had significantly more symptoms of depression 
(mean=13.0; SD=10.5 vs mean=6.2; SD=4.2) and used a more emotion-oriented coping style 
(mean=33.9; SD=10.1 vs mean=28.5; SD=8.2). Unemployed patients also scored worse on the 
cognitive screening test MoCA (mean=24.7; SD=2.9 vs mean=26.7; SD=2.8) than employed 
patients and needed more time to complete the cognitive functioning tasks of information 
processing TMT-A (mean=50.3; SD=29.8 vs mean=33.0; SD=12.3) and divided attention TMT-B 
(mean=110.9; SD=44.7 vs mean=73.7; SD=28.9). Moreover, unemployed patients had a lower 
community integration score (mean=14.0; SD=4.1 vs mean=17.5; SD=4.2), and more unmet 
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needs (mean=4.3; SD=5.5 vs mean=2.2; SD=2.1) than employed patients. The subgroup 
outcomes are presented in Table II. Multivariable logistic regression analysis showed that female 
gender, higher age of onset, higher depression score (CES-D) and worse cognitive functioning 
(MoCA) were independently associated with unemployment 4 years after SAH (Table III).
table ii. Demographic and clinical patient characteristics for employed and unemployed 
patients (N=67).
Employed
n=22
mean ± SD
Unemployed 
n=45
mean ± SD p-value
Comorbidity
Comorbidity score (CIRS) 5.3 ± 3.6 7.2 ± 4.8 0.098
Depression
Depression score (CES-D) 6.2 ± 4.2 13.0 ± 10.5 <0.001
Depressed (CES-D >16), n (%) 1 (4.5) 15 (33.3) 0.009
Coping (CISS)
Task-oriented coping 53.8 ± 9.7 50.4 ± 13.0 0.277
Emotion-oriented coping 28.5 ± 8.2 33.9 ± 10.1 0.034
Avoidance-oriented coping 38.1 ± 11.3 36.4 ± 11.0 0.560
Cognitive Functioning
Cognitive Functioning score (MoCA) 26.7 ± 2.8 24.7 ± 2.9 0.010
Mild cognitive impairment (18-26), n (%) 10 (45.5) 34 (75.6) 0.015
Attention and Concentration
Trail Making Test, part A 33.0 ± 12.3 50.3 ± 29.8 0.002
Trail Making Test, part B 73.7 ± 28.9 110.9 ± 44.7 <0.001
Community Integration (CIQ)
Total score 17.5 ± 4.2 14.0 ± 4.1 0.002
   Home Competency score 6.1 ± 3.0 6.4 ± 2.6 0.693
   Social Integration score 7.7 ± 2.0 6.5 ± 2.3 0.035
   Productive Activity score 3.6 ± 0.8 0.9 ± 1.5 <0.001
Unmet Needs (SNAQ)
Total unmet needs 2.2 ± 2.1 4.3 ± 5.5 0.034
CIRS: Cumulative Illness Rating Scale; CES-D: Center for Epidemiological Studies Depression scale; CISS: Coping In-
ventory for Stressful Situations; MoCA: Montreal Cognitive Assessment CIQ: Community Integration Questionnaire; 
SNAQ: Southampton Needs Assessment Questionnaire; 
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table iii. Variables associated with unemployment 4 years after SAH.
B p-value oR 95% Ci
Age (at onset) 0.169 0.008 1.184 1.20-1.31
Gender (women vs men) 2.567 0.002 13.030 1.96-86.70
Depression score (CES-D) 0.118 0.031 1.126 1.01-1.25
Cognitive Functioning score (MoCA) -0.338 0.036 0.713 0.52-0.99
CES-D: Center for Epidemiological Studies Depression scale; MoCA: Montreal Cognitive Assessment; OR odds ratio; 
CI confidence interval.
Unemployment
Community integration
The mean Community Integration score was 15.2 (SD 4.4) out of a maximum score of 25. 
None of the patients reached the maximum score of 25, and 50% of the patients scored 
between 12 and 19. Highest scores were found in the subdomains Home Competency 
(mean=6.3; SD=2.7) and Social Integration (mean=6.9; SD=2.3) and a relatively low score 
was found in the subdomain Productive Activity (mean=1.8; SD=1.8). Table II presents the 
scores per subgroup of employment status.
Age, comorbidity score, depression score, divided attention score (TMT-B), and unmet needs 
score were significantly associated with community integration (Table IV). Multivariable 
linear regression analyses showed that an higher age of onset (B=-0.17; p<0.001), higher 
comorbidity score (B=-0.25; p=0.023), and more unmet needs (B=-0.25; p=0.018) were 
independently related to a lower community integration score (R2=0.32).
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table iV. Variables associated with community integration.
B p-value B p-value
Age (at onset) -0.16 0.002 -0.17 <0.001
Gender (men) -0.14 0.200
Living with a partner (yes) -1.07 0.384
Education (years) -0.08 0.546
SAH type (aneurysmal) -1.23 0.463
Length of stay (days) -0.02 0.666
WFNS grade (good vs poor) 0.83 0.529
Comorbidity (CIRS) -0.38 0.001 -0.25 0.023
Depression score (CES-D) -0.15 0.016 - ns
Cognitive Functioning score (MoCA) 0.31 0.104
TMT-A -0.29 0.161
TMT-B -0.33 0.010 - ns
Task-oriented coping (CISS) 0.08 0.104
Emotion-oriented coping (CISS) -0.04 0.514
Avoidance-oriented coping (CISS) 0.09 0.085
Unmet Needs (SNAQ) -0.24 0.041 -0.25 0.018
CIQ: Community Integration Questionnaire; CISS: Coping Inventory for Stressful Situations; SNAQ: Southampton 
Needs Assessment Questionnaire; CIRS: Cumulative Illness Rating Scale; CES-D: Center for Epidemiological Studies 
Depression scale; MoCA: Montreal Cognitive Assessment; ns: non-significant
Community integration score
Univariable multivariable
DiSCUSSioN
Four years after SAH 67.2% of patients were unemployed, 67.2% reported unmet needs, and 
the mean score for community integration was 15.2 (SD 4.4). Unmet needs were inversely 
related to community integration. The high proportion of unmet needs is comparable to 
figures found in young stroke survivors >1 year after stroke.13,29 The highest proportion 
was found for unmet information needs; almost 60% of the patients indicated one or 
more unmet needs in this category. Low et al. (2003) and Kersten et al. (2002) also found 
provision of information about strokes to be the most frequently reported unmet need in 
young stroke patients.13,29 Despite the availability of patient information about stroke on 
CHAPTER 5
83
websites, booklets and patient forums, specific information for the subgroup of patients 
with SAH may be lacking.13 Because the general stroke group is older, the information given 
may not apply to younger SAH patients.30 Therefore, future research should reveal whether 
tackling unmet needs, specifically with regard to information on the causes, consequences 
and prevention of SAH, may be beneficial for patients with SAH.
We showed that the unmet needs score was independently associated with community 
integration 4 years after SAH. The total community integration score of 15.2 (SD 4.4) 
in the current study is somewhat higher than for example the scores found in patients 
with TBI (mean=14.3; SD=5.52), brain tumours (mean=13.3; SD=5.54) and neurological/ 
neuropsychiatric disorders (mean=12.6; SD=4.23).17,31,32 Equivalent scores were found 
on the Social Integration scale across these samples. On the Home Competency scale 
we found higher scores in SAH patients compared to TBI patients. This may possibly be 
explained by gender differences between the patient populations; 60% of SAH patients 
is female, whereas 75% of TBI patients is male. Women appear to have significantly higher 
scores on the Home Competency scale than men.32 In our study, only 32.8% of patients 
were employed 4 years after SAH. Comparable proportions of long-term employment after 
SAH (35-44%) were found in other studies.13,15,33 The employment proportion in our study 
cannot be compared with return-to-work proportions in some other studies, in which 
only previously employed persons are selected. For example, Passier et al. (2011) found 
that 61.4% of previously employed patients with SAH returned to work, of which only 
35.1% had completely resumed their former work within 2 to 3 years follow-up.10 In line 
with Kersten et al. (2002), we found that unemployed patients reported more unmet needs 
than employed patients.13 Moreover, we showed that unemployed patients had worse 
cognitive functioning scores than employed patients, which is also in accordance to other 
studies.7,33 Although we did not find an independent relationship between unmet needs 
and employment status, we did find that the level of unmet needs was independently 
related to the level of community integration. 
Likewise, we found that older patients showed lower levels of community integration. 
A similar age effect was found in patients with TBI and adults with neurological/
neuropsychiatric disorders.32,34 As patients with SAH are usually older than TBI patients, the 
total community integration score can be assumed to be fairly good. However, compared 
to controls or to retrospectively obtained pre-TBI total scores, patients with SAH do show 
restrictions in community integration.18,34 Comorbidity score was also related to community 
integration. This is in line with Carter et al. (2000), who described depression and physical 
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disability as important factors associated with impaired overall reintegration 1-6 years 
post SAH and with Baseman et al. (2010), who found that functional status, depression 
and overall stroke recovery were related to social integration >6 months after ischemic 
stroke.35,36 These studies show that limitations both in physical and psychosocial health are 
barriers to community integration.35
Limitations
This study has some limitations. First of all, the lack of appropriate norm scores for CIQ-
Revised made it difficult to draw conclusions from these scores. Further, no causal 
relationships could be established, because all outcome variables are measured at the 
same point in time. Finally, due to the relatively small number of patients, the number of 
variables that could be included in the regression analyses was limited. 
CoNCLUSioN
The results of this study suggest that 4 years after SAH a large proportion of patients is 
unemployed and faces unmet needs with an inverse relationship between unmet needs 
and community integration. Future research should investigate if dealing with unmet needs, 
by for example expanding and improving information services, especially for patients with 
SAH, contributes to a better community integration of these patients.
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ABStRACt
objective: To assess the relationship of coping style with depression, burden and life 
satisfaction in caregivers of patients with subarachnoid haemorrhage.
Design: Cross-sectional study.
Participants: Forty-one primary caregivers of patients with subarachnoid haemorrhage.
methods: Caregivers completed several questionnaires within the first year after 
subarachnoid haemorrhage. Coping style was assessed using the Utrecht Coping 
List, depression with the Goldberg Depression Scale (GDS), burden with the Sense of 
Competence Questionnaire, and life satisfaction with the Life Satisfaction Questionnaire.
Results: Caregivers had a mean burden score of 37.8 (SD 7.4) and a life satisfaction score of 
5.0 (SD 0.6). Nine caregivers (23%) had depressive symptoms (GDS≥2). A palliative coping 
style was positively associated with the presence of depressive symptoms (OR=1.45; 
p=0.016). A passive coping style was positively related to burden (ß=1.61; p=0.024), adjusted 
for morbidity of the caregiver (ß=11.90; p=0.013), and inversely related to life satisfaction 
(ß=-0.10; p=0.025).
Conclusion: In caregivers of patients with subarachnoid haemorrhage palliative or passive 
coping styles are related to depressive symptoms, higher burden and life dissatisfaction. 
This implies that rehabilitation programmes for patients with subarachnoid haemorrhage 
should also include caregiver support programmes that focus on coping style.
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iNtRoDUCtioN
Subarachnoid haemorrhage (SAH) is a subtype of stroke, which accounts for 5% of all cases 
of stroke. SAH is caused, in approximately 85% of cases, by a ruptured aneurysm in one 
of the cerebral vessels. The incidence of SAH in the Netherlands is 5.7 for men and 9.9 for 
women per 100,000 persons per year.1,2 Compared with stroke in general, SAH occurs at 
a fairly young age: 50% of patients are younger than 55 years of age.3 Three months after 
SAH, 47% of patients experience mild cognitive impairments, 25% severe cognitive deficits 
and 40% depressive symptoms.4 One to 5 years after SAH, even in patients with good and 
fair recovery (Glasgow Outcome Score 5 and 4, respectively), there can still be cognitive 
deficits in all neuropsychological domains, with a high percentage of patients experiencing 
depression and reduced life-satisfaction.5 In research SAH is often clustered with other forms 
of stroke, therefore it is difficult to distinguish the unique consequences of this subtype.6
Persistent psychosocial consequences are reported by the primary caregivers of patients 
with SAH, affecting quality of life, personal lives, family relations, financial situation and 
mood. Hop et al. (1998) and (2001) found that after 4 months, and even after 18 months, 
SAH had considerable impact on the quality of life of the partners.7,8 Buchanan et al. (2000) 
studied patients with SAH who underwent surgery.9 Their relatives reported psychological 
distress and 66% reported moderate or high levels of family burden.9 Forty percent of 
caregivers found it easier to deal with the initial crisis than to cope with the consequences 
after hospital discharge.10 Financial problems are reported by one-third of caregivers.10 Two 
to 3 years after SAH, 54% of caregivers experienced social or emotional stress.11 A study 
by Noble et al. (2008) showed that 3.5 months after SAH, almost 26% of caregivers had 
post-traumatic stress disorder (PTSD).12 Because caregivers play an important role in the 
recovery of a patient with SAH (e.g. in maintaining treatment and emotional support), the 
consequences above imply that post-acute rehabilitation after SAH should focus not only 
on the patient but also on his or her caregiver.7-11 To our knowledge there is no literature 
about specific caregiver support programmes for caregivers of patients with SAH.
Little is known about coping in relation to psychosocial functioning of the primary caregivers 
of patients with SAH. There is evidence that a passive coping style is related to quality of 
life and burden in acquired brain injury (ABI) in general, and more specifically, in stroke and 
traumatic brain injury (TBI) populations.13-17 Only one study of caregivers of patients with 
SAH was found: Noble et al. (2008) concluded that maladaptive coping strategies seem to 
be a predictor of PTSD in caregivers of patients with SAH.12 This study also suggests that 
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these caregivers need greater attention and support, for example, by teaching them better 
coping strategies. 
Another reason for studying caregivers of patients with SAH is that they differ from caregivers 
of patients with general stroke. Caregivers of patients with SAH are much younger and in 
different stage of life when the haemorrhage occurs compared with caregivers of patients 
with other types of stroke.18 In order to improve caregiver support programmes, it is 
important to understand which caregivers are at risk of long-term psychosocial distress. If 
the coping style of the caregiver relates to psychosocial distress and quality of life, training 
active coping styles could be a target for improving caregiver support programmes. The 
current study therefore assesses the relationship of the caregiver’s coping style with 
depression, burden and quality of life of primary caregivers of patients with SAH. 
mEtHoDS
Participants 
Between May 2006 and May 2009 patients diagnosed with SAH, admitted to the neurology 
or neurosurgery department of the Erasmus University Medical Center Rotterdam (Erasmus 
MC), and their primary caregivers were asked to participate in a prospective cohort study 
on long-term functional outcome after SAH. This study in caregivers is a cross-sectional 
substudy of a longitudinal study in patients with SAH. Patients were included if they were 
diagnosed with SAH and were 18 years of age or older. Caregivers were included if they 
were the primary caregiver of the patient and if they were at least 18 years of age. Exclusion 
criteria for patients and caregivers were: inability to complete the questionnaires because 
of aphasia or cognitive impairment, no mastery of the Dutch language, or a short life 
expectancy (less than 1 year) due to comorbidity. Written informed consent was obtained 
from all participants. The study was approved by the Medical Ethics Committee of the 
Erasmus MC.
Data collection
Clinical characteristics and socio-demographic data of the patients with SAH were collected 
during hospital stay by the staff of the neurology or neurosurgery department. Within one 
year post-onset, patients and their primary caregivers were visited at home by a trained 
research psychologist to complete a set of validated questionnaires. Data collected from 
the caregivers were: age, gender, education level and morbidity. Morbidity of the caregiver 
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is designed as a dichotomous variable where the caregiver was asked if he or she had 
health problems and/or relational stressors requiring treatment. The outcome measures 
assessed with validated questionnaires included depression, quality of life, coping style, 
and burden. 
Measurement instruments 
Glasgow Coma Scale (GCS) scores were collected as a measure of the severity of the 
patients’ SAH. The GCS score is composed of 3 components of impaired consciousness 
and coma: motor response, verbal response and eye opening. The total score ranges from 
3 to 15, of which the higher scores represent a higher level of consciousness.19 The GCS 
scores, in combination with absent or present motor deficits, are transformed into World 
Federation of Neurological Surgeons (WFNS) scales, which is a universal SAH grading scale 
in 5 categories, ranging from 1 (no symptoms) to 5 (severe symptoms).20,21 The Barthel Index 
(BI) was used to measure physical functioning of the patient based on the independence 
of performing activities of daily living; it ranges from 1 (severe disabilities) to 20 (without 
disabilities).22 The Mini-Mental State Examination (MMSE) was used to evaluate cognitive 
functioning of the patient.23 
The Goldberg Depression Scale (GDS) was used to assess symptoms of depression in the 
primary caregivers of patients with SAH. This scale consists of 9 questions with yes/no 
answers and has a total score range of 0-9, with higher scores indicating more depressive 
feelings. A cut-off score of 2 or more has been found to yield good specificity (93%) and 
sensitivity (85%) in terms of assessing depression in a general population.24
The Sense of Competence Questionnaire (SCQ) was used to assess the burden of the 
caregivers. This questionnaire has been proven to be a reliable and valid instrument for 
assessing the burden of care-giving as experienced by caregivers of patients with stroke.25 
The SCQ consists of 27 items on 3 subscales: satisfaction with the patient as a recipient 
of care (7 items), satisfaction with one’s own performance as a caregiver (12 items) and 
consequences of involvement in care for the personal life of the caregiver (8 items). Each 
item was graded on a 4-point rating scale, ranging from 1 to 4. The burden scores for 
the total and the 3 subdomains are represented as the sum of the item scores. The total 
score ranges from 27 to 108, with a higher score representing a higher level of perceived 
burden.26 To differentiate between high and low burden, we used a cut-off score of >42 for 
high burden. This cut-off score is based on the description of normal cognitive functioning 
given by Scholte op Reimer et al. (1998).25
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Life satisfaction was measured with the Life Satisfaction Questionnaire (LiSat-9). This 
questionnaire consists of 9 items: satisfaction with life as a whole, and 8 life domains. The 
scores range from 1 (very dissatisfying) to 6 (very satisfying). Scores of 1-4 depict degrees 
of dissatisfaction, and scores of 5-6 depict degrees of satisfaction. The total score consists 
of the mean of all 9 items scores and has shown good internal consistency and reliability 
(Cronbach’s alpha coefficient = 0.82).15,27,28 The Dutch version has been validated in an ABI 
population.29
Coping style was measured with the Utrecht Coping List (UCL), a questionnaire with an 
acceptable internal reliability and test-retest correlation. The UCL has 44 items in 7 sub-
scales, each representing a coping strategy. Caregivers have to respond to the question 
“How often do the following behaviours apply to you?” by answering on a 4-point scale 
from never (1) to very often (4). The 7 subscales are: “Passive” (7 items), which includes 
isolating oneself from others, worrying about the past and taking refuge in fantasies; 
“Active confronting” (7 items), described as tackling a problem at once, seeing problems as 
a challenge and remaining calm in difficult situations; “Palliative” (8 items), which represents 
seeking distraction by trying to relax, going out or decreasing pressure by smoking or 
drinking alcohol; “Seeking social support” (6 items), which includes asking for help and 
sharing worries with someone; “Avoiding” (8 items), which means to let things take their 
course and wait to see which way the wind blows; “Expressing emotions” (3 items), which 
represents showing anger and letting off steam; and “Reassuring thoughts” (5 items) to 
encourage and telling oneself that everything will be alright. Sum scores were used per 
subscale.30,31 
Data analysis
Statistical analyses were performed using SPSS version 19 (SPSS Inc, Chicago, USA). 
Descriptive analyses were used to express the patient and caregiver characteristics. The 
coping style mean scores were compared with the normal ranges in the norm tables (I and 
II) in the UCL manual.30 Multivariate linear and logistic regression analyses were performed 
to estimate the relation of coping style with depression, burden and life satisfaction 
in caregivers of patients with SAH. The model assumptions of linearity, normality and 
homoscedasticity were checked. Because the residuals of the depression variable were 
not normally distributed, due to the high number of zero scores, this variable (GDS) was 
dichotomized into yes/no for the presence of depression, based on the cut-off score of 2. 
The relation of coping style with the presence of depression was assessed with a logistic 
regression analysis, and burden and life satisfaction were analysed using linear regression 
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analyses. The following potential confounders were taken into account: the severity of SAH 
of the patient measured with the GCS, and age, gender, education level and presence of 
morbidity of the caregiver. 
First, each variable was analysed separately with univariate regression analysis. If a significant 
relationship was found at a p-value<0.05, the variable was entered into a multivariate 
regression analysis using forward variable selection. If the p-value was >0.10 the variable 
was removed from the multivariate regression model.
RESULtS
Patient and caregiver characteristics 
During the inclusion period, a total of 228 patients with SAH were admitted to the neurology 
or neurosurgery department of the Erasmus University Medical Center, of which, 63 patients 
died. All 165 surviving patients were asked to participate in the study before hospital 
discharge. Of these, 20 patients refused to participate, 30 did not meet the inclusion criteria 
and 48 were discharged before informed consent was obtained. A total of 67 SAH patients 
agreed to take part in the study. The primary caregiver of each included patient was also 
asked to participate in the study. Of these, 41 (61%) agreed to participate. The caregiver 
study population mainly consisted of spouses (n=35; 85%), with the remainder comprising 
of children (n=3; 7%) or parents (n=3; 7%) of the patients. The majority of the caregivers 
were men (59%). Ages ranged from 27 up to 79 years (mean=56.3; SD=13.4). The patient 
and caregiver characteristics are shown in Table I.
Outcomes of the caregivers
Caregivers were measured within 1 year after patients’ SAH (mean=4.4 months; SD=3.8). 
Nine caregivers (23%) were classified as depressed (GDS≥2). The mean score on the LiSat-9 
of 5.0 (SD 0.6) indicates that, in general, the caregivers were satisfied with life. Ten caregivers 
(28%) scored <5, indicating they were dissatisfied with life. Of the SCQ there were only 
21 complete questionnaires, because this test was added later during the study. Of these 
21 caregivers, 6 (29%) scored higher than 42, which indicates that they experienced high 
burden. All coping style subscores were in the normal ranges of age norm groups as 
described in the UCL manual.30 All total mean scores and frequencies of these caregiver 
outcomes are shown in Table II. 
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outcome n (%) mean (SD) median (iQR)
GDS (0-9) 1.0 (2.0) 0 (0-1)
   Depression (GDS≥2) 9 (23)
SCQ total (27-108) 37.8 (7.4) 35 (32-44)
   Satisfaction as recipient (7-28) 9.1 (1.8) 9 (8-10)
   Satisfaction with own performance (12-48) 16.4 (4.9) 15 (13-19)
   Consequences of involvement (8-32) 12.3 (3.6) 12 (9-16)
   Presence of burden (SCQ>42) 6 (29)
LiSat-9 (1-6) 5.0 (0.6) 5.2 (4.9-5.4)
   Dissatisfied (LiSat-9<5) 10 (28)
UCL
   Active (7-28) 18.8 (3.4) 19 (16-21)
   Palliative (8-32) 16.4 (2.9) 16 (14-17)
   Avoiding (8-32) 14.4 (3.2) 14 (12-16)
   Seeking social support (6-24) 12.7 (2.3) 12.5 (11-15)
   Passive (7-28) 10.6 (2.3) 10 (9-12)
   Expressing emotions (3-12) 5.6 (1.3) 6 (5-6)
   Reassuring (5-20) 12.4 (1.9)  12 (11-14)
Missing data: GDS: n=2, SCQ: n=20, LiSat: n=5, UCL: n=1.
SAH: subarachnoid haemorrhage; UCL: Utrecht Coping List; GDS: Goldberg Depression Scale; SCQ: Sense of 
Competence Questionnaire; LiSat-9: Life Satisfaction Questionnaire; SD: standard deviation; IQR: inter quartile 
range.
Relationships between coping styles and outcomes
Results of the logistic and linear regression analyses are shown in Table III.
A palliative coping style was positively associated with the presence of depressive symptoms 
(OR=1.45; p=0.016). None of the potential confounders was significantly associated with the 
presence of depression.
Passive coping style (p=0.025), morbidity of the caregiver (p=0.010), and gender (p=0.024) 
were significantly related to burden in univariate analyses. In the multivariate model, 
a passive coping style was positively related to burden (ß=1.61, p=0.024), adjusted for 
table ii. Outcomes for caregiver depression, burden, life satisfaction and coping strategy 
(n=41)
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morbidity of the caregiver (ß=11.90; p=0.013). Gender dropped out of the final regression 
model (R2 change=5.0%; p=0.210).
Passive coping style was inversely related to life satisfaction (ß=0.10; p=0.025). None of the 
potential confounders was significantly associated with this outcome.
table iii. Logistic and linear regression models for the 3 outcomes: presence of depression, 
burden score and life satisfaction score.
oR (95% Ci) ß (95% Ci) p-value
R2 change 
(%)
R2 total 
(%)
Presence of depression 34.3a
   Palliative coping style 1.45 (1.07; 1.97) 0.016
Burden 48.3
   Morbidity of caregiver 11.90 (2.84; 20.97) 0.013 29.8
   Passive coping style 1.61 (0.24; 2.99) 0.024 18.5
Life satisfaction 14.3
   Passive coping style -0.10 (-0.18; -0.01) 0.025
a R2 Nagelkerke.
95% CI: 95% confidence interval; OR: odds ratio.
COPING STyLES IN CAREGIVERS  OF PATIENTS WITH SAH
DiSCUSSioN
In this study, we found that maladaptive coping styles, such as passive coping and palliative 
coping, are related to depression, burden and life dissatisfaction in caregivers of patients 
with SAH. This is in line with the results of other studies among the caregivers of patients 
with ABI, which concluded that psychosocial functioning is related to caregiver coping 
styles.13-15,17,31 In particular, a passive coping style of the caregiver has been associated with 
lower family functioning, lower quality of life and higher strain.17 Visser-Meily et al. (2005) 
found that the passive coping style of the caregiver was the most important predictor of 
quality of life 1 year after stroke.15 In addition, 3 years after stroke, caregiver coping style 
seemed to be related to their psychosocial functioning: a passive coping style was related 
to negative outcomes, whereas an active coping style was related to positive outcomes.16 
In caregivers of patients with TBI, a similar correlation was found between coping style and 
perception of burden and increased emotional distress.13,14,31 Surprisingly, in our study no 
significant associations were found between active coping styles and the caregiver outcomes, 
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as in Visser-Meily et al. (2005) and (2009).15,16 This may be explained by the problem of a small 
sample size in our study or by the different outcome measures that were used.
Our finding, about the correlation between coping style and caregiver outcomes, is 
important for the development and improvement of specific SAH caregiver support 
programmes in rehabilitation services and to target those persons who might benefit from 
such programmes. If it is possible to change maladaptive coping styles into effective coping 
styles through an intervention programme, both patients and caregivers might benefit 
from such a programme. A study analysing the burden of caregivers of chronic neurological 
patients showed that approximately 66% of the caregivers requested interventions aimed 
at reducing their burden.32 In order to select persons for caregiver support programmes, 
questionnaires could be used that measure the preference for certain coping styles. Our 
study shows that caregivers with high scores on palliative or passive coping styles may 
benefit the most from such programmes. Several intervention studies for patients with 
stroke or TBI and their caregivers have focused on improving emotional functioning and 
reducing caregiver burden after TBI or stroke.33,34 Backhaus et al. (2010) found that a Coping 
Skills Group intervention in a population of patients with TBI and their caregivers resulted 
in improved perceived self-efficacy directly after participating in the group.35 This result 
is promising for our population of patients with SAH and their caregivers. Although 23% 
of caregivers of patients with SAH seemed to be depressed in this study, we also found 
that, in general, the primary caregivers of patients with SAH were satisfied with life, had 
low depression and burden scores, and showed adequate coping styles. Only 28% of 
caregivers were dissatisfied with life. These numbers are much better than those reported 
for caregivers of patients with ABI. For these caregivers, Wolters Gregório et al. (2011) 
found that 39% experienced high levels of strain and 38% reported a low quality of life.17 
In spouses of patients with stroke, 52% reported depressive symptoms, 50% dissatisfaction 
with life and 54% strain.15 An explanation for this discrepancy might be that the studies of 
caregivers of stroke or ABI patients contained cohorts of patients that were more severely 
affected, both physically and mentally, by the injury in comparison with our cohort, in which 
the majority of the patients had maximal GCS scores and Barthel Index scores.13,16,31,36 If a 
patient is severely affected by the injury this will have a greater impact on caretaking tasks 
and burden for their caregivers.34 Differences in injury severity can also be explained by 
the fact that our sample is a hospital-based cohort of patients with SAH, whereas other ABI 
cohorts are often rehabilitation cohorts and thus more severely affected.  From our cohort 
only 25% were referred to inpatient rehabilitation centres or nursing homes and 75% were 
discharged directly to their homes. 
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Finally, the high scores on the GCS and low scores on WFNS in this study might be partly 
explained by the fact that patients with perimesencephalic SAH were not excluded (10% of 
the study population). The prognosis of these patients is considered much better compared 
with patients with aneurysmal SAH.18
Study limitations
The study has some limitations. The first is that the sample size is relatively small. However, 
even with this small number, we did find significant differences in outcomes based on 
coping styles of caregivers. In further research a larger sample is required to confirm that 
palliative or passive coping styles in caregivers of patients with SAH are related to depressive 
symptoms, higher burden and life dissatisfaction. Another limitation is that the study 
has a cross-sectional design, which prevents us from drawing conclusions about causal 
relationships. No follow-up measurement was performed in this group of caregivers, and 
as such the change over time in coping styles, mood and life satisfaction was not studied. 
Finally, no distinction was made between the types of caregivers. All types of caregivers 
were grouped together, because the sample size in this study was too small to subdivide 
the group of caregivers into partners, parents and children. Further studies are required to 
determine whether there are different outcomes for these subgroups. 
CoNCLUSioN
In conclusion, palliative and passive coping styles are related to depressive symptoms, 
burden, and life dissatisfaction in caregivers of patients with SAH in the first year post-onset. 
To develop specific rehabilitation programmes for patients with SAH and their caregivers, 
more studies assessing the relationship between coping style, depression, burden and life 
dissatisfaction in caregivers of patients with SAH are required, with a longitudinal study 
design.
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The main objective of this thesis was to evaluate long-term consequences 4 years after 
subarachnoid haemorrhage (SAH), and to define which patients are in need of long-term 
professional support. Research on long-term problems experienced by patients with SAH 
is of growing importance, because in recent years, survival rates of SAH have increased.1 
To investigate these long-term outcomes, it was necessary to study a wide range of factors 
which are possibly connected to the outcomes in this group of patients. A distinction is 
made between perimesencephalic subarachnoid haemorrhage (PM-SAH) and aneurysmal 
subarachnoid haemorrhage (A-SAH), partners/caregivers are involved in the study, and 
different variables like cognitive functioning, physical and social functioning are studied. 
This chapter will discuss the main findings, strengths and limitations of this study in the 
context of the published literature. Finally, directions for future research and possible 
implications for rehabilitation programs are described.
mAiN FiNDiNGS
Perimesencephalic Subarachnoid Haemorrhage
In terms of clinical outcomes, PM-SAH is described as a benign subtype of SAH. Patients do 
not need surgery, they are not at risk for the serious complications of SAH, re-bleeding or 
delayed cerebral ischemia and do not have a higher mortality rate than healthy people.2,3 
However, based on the results of this thesis, we concluded that the outcomes for these 
patients are not that favourable. Our short term findings (Chapter 2) regarding the presence 
of fatigue in 37.5% of patients and the problems in complex cognitive functioning compared 
to norm values are confirmed in the long term (Chapter 3). Four years after PM-SAH, 33% 
of the patients experienced fatigue and 37% did not return to work. Furthermore, we 
found indications for problems in complex cognitive functioning, especially in the group of 
fatigued patients with PM-SAH. The review of Kapadia et al. (2014) gives a broad description 
about clinical, functional and cognitive outcomes in patients with PM-SAH.4 We confirm 
their findings about the difficulties with returning to work and deficits in several cognitive 
domains. Fatigue is known to be related to negative cognitive outcomes and lower rates 
of return to work 3-6 months after stroke.5 Although fatigue appears to be a long-term 
consequence of PM-SAH, it has received little attention in scientific research. Supported by 
the personal stories of the participants in our research, further research into the origin and 
consequences of fatigue after SAH seems warranted. 
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Aneurysmal subarachnoid haemorrhage 
Studies that evaluate outcomes of A-SAH survivors more than 1 year post-onset are scarce, 
and rehabilitation programs for patients with SAH usually do not expand beyond the scope 
of one year post-onset. We found that patients with A-SAH improve over time and in general 
their outcomes on all ICF domains are fairly good (Chapter 4). However, compared to 
healthy subjects, patients with A-SAH experience more fatigue, depressive symptoms and 
problems in cognitive functioning. Furthermore, 25% of the patients show problems in self-
care and 82% have behavioural difficulties in the long term on domains of ‘psychological 
autonomy and communication’ and ‘social behaviour’. Just as in the patients with PM-SAH, 
a large percentage of A-SAH patients are unemployed, even 4 years after SAH. Our findings 
are consistent with the reviews of Al-Khindi et al. (2010) and Rinkel et al. (2011).1,6
Fatigue, cognitive functioning and mood
In patients with A-SAH, as well as in patients with PM-SAH, we found fatigue and 
disturbances in cognitive functioning and mood in the long term after SAH (Chapters 2, 3, 4 
and 5). These variables are described in the literature as the 3 most common consequences 
of stroke in general with significant impact on the lives of the patients.7 Relationships 
between fatigue and anxiety, depression, Post-traumatic stress disorder, memory 
difficulties, personality changes, sleep disturbances and cognitive and physical impairment 
after A-SAH are described.6,8 The review of Abd-Elfattah et al. (2015) describes fatigue 
as a decrease in physical performance associated with an increase in the real/perceived 
difficulty of a task or exercise.9 In patients with stroke, Wu et al. (2015) makes a distinction 
in early fatigue, which may be triggered by biological factors, and late fatigue which may 
be more attributable to psychological and behavioural factors.10 Our study also established 
relations between fatigue, cognitive functioning and depression in patients with PM-SAH 
(Chapter 4). However, causal attributions cannot be made. It is not clear whether fatigue 
causes cognitive dysfunction and mood problems or if the relationship is the other way 
around. What we can tell from this research is that these problems co-exist and that follow-
up studies and intervention studies are needed to find out whether these variables change 
in the same direction or can be influenced by therapy.
Unmet needs
Four years after SAH, 67% of all patients reported one or more unmet needs and patients 
experienced less than optimal community integration (Chapter 5). A higher number of unmet 
needs is associated with a lower score on community integration. Unemployed patients 
reported more unmet needs and had lower cognitive functioning scores than employed 
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patients. The high proportion of patients with unmet needs in our study is comparable 
to the proportions found in young stroke survivors >1 year after stroke.11,12 The highest 
proportion unmet needs in our study was found for the category unmet information needs; 
almost 60% of the patients indicated one or more unmet needs in this category. Despite the 
availability of patient information about stroke on websites, booklets and patient forums, 
specific information for the subgroup of patients with SAH may be lacking.11
StRENGtHS AND LimitAtioNS
A major strength of this study is that it provides an extensive description of long-term 
outcome in patients with SAH. Studies evaluating the outcomes of SAH survivors longer 
than 1 year post-onset are scarce, most studies have a retrospective design and focus on 
a single outcome.13,14 In line with Lezak (1988), who determined that brain damage not 
only is of negative influence on the patients’ quality of life, but also affects the well-being 
of patients’ families,15 we involved caregivers in our study, which is another important 
strength.
In addition, we studied long-term cognitive functioning and fatigue in patients with 
PM-SAH (Chapter 3). This group of patients is considered to have a favourable outcome 
and is often excluded from outcome studies. Earlier studies on non-aneurysmal or PM-SAH 
patients concerned small numbers of patients.16-19 In our collaboration with Utrecht Medical 
Center, we managed to study a relatively large group of PM-SAH patients (N=46). 
Our study has several limitations too. First of all, due to the small sample size the number 
of variables that could be included in regression analyses was limited. However, even with 
small numbers, we did find significant differences between patients with PM-SAH and 
A-SAH and between our sample and norm values of healthy people. Especially in our 
studies on patients with PM-SAH and caregivers of patients with SAH, the absence of short-
term measurements and follow-up measurements is considered a limitation of this study, 
because causal relationships could not be studied. At T1 we also had to deal with missing 
data, due to incomplete questionnaires, variety of research assistants and the capacity of 
some of the participants. Despite this, the mean outcomes of the total study population 
could be reliably estimated by using modern statistical methods.
GENERAL DISCUSSION
CH
A
Pt
ER
 7
112
RECommENDAtioNS FoR FUtURE RESEARCH
In general, more long-term, longitudinal studies on larger groups of patients with SAH are 
necessary to draw further, and more accurate conclusions on the long-term outcomes of 
these patients involving caregivers and patients with both A-SAH and PM-SAH.
As fatigue is an important factor throughout this thesis, future research aimed at unravelling 
the underlying mechanisms is necessary if we are to come to an individually tailored 
treatment for patients with SAH. To evaluate fatigue is difficult, and the best manner of 
measuring fatigue is subject to discussion. In our studies we used the Fatigue Severity Scale 
(FSS), a simple scale which is often used in TBI research.20 However, the FSS items are more 
related to behavioural consequences of fatigue, rather than fatigue characteristics. Other 
questionnaires could be used, such as the Multidimensional Fatigue Inventory (MFI), which 
makes a distinction between several types of fatigue for a better understanding of the 
origin of fatigue.21
Furthermore, because patients with SAH still experience problems 4 years after onset, it 
should be questioned if rehabilitation services can adapt their programs to incorporate 
long-term needs of patients with SAH. 
Finally, future research should include patients with PM-SAH. These patients are under-
represented in the scientific literature. 
CLiNiCAL imPLiCAtioNS
With fatigue being a recurring theme throughout this thesis, and possibly related to other 
problems in long-term outcomes, screening for fatigue, and long-term fatigue management 
in the treatment for patients with SAH can be advised.1,6 Furthermore, as cognitive problems 
may remain in the long term, not only in patients with A-SAH but also in PM-SAH, these 
should be anticipated by health care professionals and communicated to patients and their 
caregivers. Finally, many patients pointed out a need for more information specific to SAH, 
so this topic deserves more emphasis both in patient associations and in rehabilitation 
institutes. 
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The introductory Chapter 1 provides background information about subarachnoid 
haemorrhage (SAH) and gives a short overview of the current knowledge of its long-term 
impact on the lives of patients. The chapter explains the main objective of this thesis, which 
is to gain more knowledge about the long-term consequences four years after subarachnoid 
haemorrhage, and to define which patients are in need of long-term professional support.
Compared to aneurysmal SAH (A-SAH), perimesencephalic SAH (PM-SAH) often is 
considered to have a more favourable outcome. The aim of Chapter 2 is to compare outcome 
between patients with A-SAH and PM-SAH in the first year post-onset. The results indeed 
showed that patients with PM-SAH had less depression and fatigue, and were faster on the 
cognitive task for motor speed and processing speed, than patients with A-SAH. Compared 
with norm scores, patients with A-SAH scored worse on all tests, while patients with PM-
SAH scored worse on the TMT-B, used to measure complex cognitive functioning, and had 
higher fatigue scores measured with the FSS. These results suggest that patients with PM-
SAH may also suffer from long-term consequences that interfere with daily activities and 
social participation. We conclude that one year post-onset, both patients with A-SAH and 
PM-SAH may be in need of professional support. More research is needed to confirm these 
findings.
In Chapter 3 we subsequently studied fatigue and cognitive functioning in a larger group 
of patients with PM-SAH in collaboration with the University Medical Center in Utrecht. Four 
years after PM-SAH, 33% of patients with PM-SAH experienced fatigue and experienced 
problems in the cognitive functioning domains: attention and concentration, speed 
of information processing, and memory. The fatigue score was found to be significantly 
associated with subjective and objective cognitive functioning, mood and comorbidity. 
Even after adjustment for mood and comorbidity, fatigue remained associated with 
attention and executive functioning. These results underscore that even four years post-
onset patients may face the negative impact of PM-SAH.
Chapter 4 is focused on patients with A-SAH with a four-year follow-up. Multiple outcomes 
for depression, fatigue, cognitive functioning, independence, health-related functioning, 
participation, social support, locus of control, and quality of life were tested, based on the 
International Classification of Functioning, Disability and Health. Changes over time were 
assessed and the four-year outcomes were compared with norm scores. We found that the 
scores for Barthel Index, TMT-B, SSL-12 (total score and esteem support), MHLCS physician-
orientation, and SF-36 (role emotional) improved over time, whereas scores for CES-D, FSS, 
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SIP-68 and SF-36 (remaining scores) remained the same. At four-year follow-up, patients 
were slower on the cognitive functioning task TMT-A and TMT-B, had higher fatigue scores, 
and a higher proportion of depression than norm scores. Furthermore, we found that 69% of 
patients were unemployed and 82% experienced difficulties on the domains psychological 
autonomy and communication, and social behaviour of the SIP-68. We therefore conclude 
that four years post-onset, problems in executive functioning, mood and fatigue were 
present. 
In Chapter 5 we assessed whether patients with A-SAH and PM-SAH experience unmet 
needs in relation to community integration and employment status four years after 
SAH. The results of this study show 67.2% of patients with unmet needs and 67.2% with 
unemployment. Almost 60% of patients reported a need for more information; unemployed 
patients had more unmet needs than employed patients. Finally, an inverse relation between 
unmet needs and community integration was found. It was concluded that future research 
is necessary to investigate whether expanding and improving information services may 
contribute to a better community integration in patients with SAH. 
In Chapter 6 we focussed on the impact of PM-SAH and A-SAH on the caregivers seven 
months post-onset. The relationships of coping style with depression, burden and life 
satisfaction in these caregivers was studied. Overall we found that the caregivers were 
satisfied with life, had low depression and burden scores and showed adequate coping 
styles. Caregivers with a preference for more palliative or passive coping styles had more 
depressive symptoms, higher burden and life dissatisfaction.
Chapter 7 is the general discussion of this thesis, which describes the main findings, 
discusses the relations between fatigue, cognitive functioning and mood, and points out 
the importance of unmet needs in relation to community integration. Further, the strengths 
and limitations of this study are discussed, recommendations for future research are made 
and clinical implications are addressed. 
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Samenvatting
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Het inleidende hoofdstuk 1 geeft achtergrondinformatie over subarachnoïdale bloedingen 
(SAB) en geeft tevens een kort overzicht van de huidige kennis van de langetermijngevolgen 
voor het leven van de patiënt. Dit hoofdstuk beschrijft de belangrijkste doelstelling van dit 
proefschrift, namelijk het verkrijgen van meer kennis over de langetermijngevolgen vier 
jaar na een SAB en om te bepalen welke patiënten langdurige professionele ondersteuning 
nodig hebben.
Vergeleken met een aneurysmatische bloeding (A-SAB), wordt de perimesencefale 
bloeding (PM-SAB) vaak beschouwd een gunstiger uitkomst te hebben. Het doel van 
hoofdstuk 2 is om de uitkomsten in het eerste jaar na het ontstaan van een SAB te 
vergelijken tussen patiënten met A-SAB en PM-SAB. De resultaten toonden inderdaad aan 
dat patiënten met PM-SAB minder last hadden van depressie en vermoeidheid en dat ze 
sneller waren dan patiënten met A-SAB op de cognitieve taak voor het meten van motor- en 
verwerkingssnelheid (TMT-A). Vergeleken met normscores scoorden patiënten met een A-
SAB slechter op alle testen, terwijl patiënten met PM-SAB langzamer waren op de complex 
cognitief functioneren taak (TMT-B) en meer last hadden van vermoeidheid, gemeten met 
de FSS. Deze resultaten suggereren dat ook patiënten met een PM-SAB op de lange termijn 
last kunnen hebben van gevolgen die interfereren met dagelijkse activiteiten en sociale 
participatie. We kunnen hieruit concluderen dat zowel patiënten met A-SAB als patiënten 
met een PM-SAB één jaar na de bloeding mogelijk behoefte hebben aan professionele 
ondersteuning. Meer onderzoek is nodig om deze resultaten te bevestigen.
Vervolgens hebben we in hoofdstuk 3 bij een grotere groep patiënten met PM-SAB 
vermoeidheid en cognitief functioneren onderzocht in samenwerking met het Universitair 
Medisch Centrum Utrecht. Na vier jaar ondervond 33% van de patiënten met een PM-SAB 
vermoeidheid en problemen met cognitief functioneren op de domeinen aandacht en 
concentratie, snelheid van informatieverwerking en geheugen. De vermoeidheidsscore 
was significant geassocieerd met subjectief en objectief cognitief functioneren, stemming 
en co-morbiditeit. Zelfs na correctie voor stemming en co-morbiditeit, bleef vermoeidheid 
geassocieerd met aandacht en executieve functies. Deze resultaten benadrukken dat 
patiënten, zelfs vier jaar na het ontstaan van de bloeding, geconfronteerd kunnen worden 
met de negatieve gevolgen van een PM-SAB.  
Hoofdstuk 4 richt zich op patiënten met een A-SAB die vier jaar gevolgd werden. 
Verschillende uitkomstmaten voor depressie, vermoeidheid, cognitief functioneren, 
onafhankelijkheid, gezondheid-gerelateerd functioneren, participatie, sociale steun, 
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locus of control en kwaliteit van het leven werden getest op basis van het ICF-model 
(International Classification of Functioning, Disability and Health). Veranderingen in de 
tijd werden gemeten en langetermijnresultaten werden vergeleken met normscores. We 
vonden vooruitgang op de scores van de Barthel Index, TMT-B, SSL-12 (totale score en 
waarderingssteun), MHLCS (arts-oriëntatie), en SF-36 (emotionele rol), terwijl de scores 
op de CES-D, FSS, SIP-68 en SF-36 (overige scores) gelijk bleven. Na vier jaar follow-up 
vonden we dat patiënten met een A-SAB slechter scoorden op de cognitief functioneren 
taken (TMT-A en TMT-B), hogere vermoeidheid scores (FSS) hadden, en dat een groter 
percentage patiënten depressieve klachten had dan norm groepen. Daarnaast vonden we 
dat 69% van de patiënten niet werkten en dat 82% problemen ondervond op de domeinen 
psychologische autonomie en communicatie en sociale participatie (SIP-68). Uit deze 
resultaten kunnen we concluderen dat vier jaar na het ontstaan van de bloeding, patiënten 
problemen ervaren met executieve functies, stemming en vermoeidheid.
In hoofdstuk 5 onderzochten we of patiënten met A-SAB en PM-SAB onvervulde behoeften 
(unmet needs) ervaren met betrekking tot integratie in de samenleving en arbeidssituatie 
vier jaar na SAB. De resultaten van deze studie laten zien dat 67.2% van de patiënten werkloos 
is en 67.2% onvervulde behoeften heeft. De belangrijkste onvervulde behoefte blijkt de 
behoefte aan informatie te zijn en wordt door bijna 60% van de patiënten gerapporteerd. 
Daarnaast hebben werkloze patiënten meer onvervulde behoeften dan patiënten die wel 
werk hebben. Tenslotte vinden we een inverse relatie tussen onvervulde behoeften en 
integratie in de samenleving. Hieruit kunnen we concluderen dat er verder onderzoek nodig 
is om te bekijken of uitbreiding en verbetering van informatievoorzieningen bijdraagt aan 
betere integratie in de samenleving van patiënten met een SAB.
In hoofdstuk 6 hebben we ons gericht op de gevolgen van een A-SAB en een PM-SAB op 
de mantelzorgers van de patiënten. We hebben de relatie van coping stijl met depressie, 
belasting en tevredenheid met het leven bij deze mantelzorgers onderzocht. Over het 
algemeen waren de mantelzorgers in deze studie tevreden met het leven, hadden ze 
lage depressie- en belasting scores en lieten ze adequate coping stijlen zien. Tevens laten 
de resultaten zien dat een voorkeur hebben voor palliatieve of passieve coping stijlen 
gerelateerd is aan meer depressieve symptomen, hogere belasting en ontevredenheid met 
het leven binnen de groep mantelzorgers van patiënten met SAB.
Hoofdstuk 7 is de algemene discussie van dit proefschrift, welke de belangrijkste 
bevindingen beschrijft, de relatie tussen vermoeidheid, cognitief functioneren en 
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stemming bespreekt en wijst op het belang van het hebben van onvervulde behoeften in 
relatie tot integratie in de samenleving. Verder worden de sterke- en zwakke punten van 
deze studie besproken, doen we aanbevelingen voor toekomstig onderzoek en geven we 
enkele klinische implicaties aan die voortvloeien uit dit onderzoek.
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